0.070.080.180.020001844862--12-312023Q2false0.070.080.180.02P3Y1760071841783268900001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputSharePriceMember2023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputPriceVolatilityMember2023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExpectedTermMember2023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExercisePriceMember2023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputSharePriceMember2022-12-310001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2022-12-310001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputPriceVolatilityMember2022-12-310001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExpectedTermMember2022-12-310001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExercisePriceMember2022-12-310001844862us-gaap:CommonStockMember2023-01-012023-03-310001844862us-gaap:CommonStockMember2022-01-012022-03-310001844862us-gaap:CommonStockMember2022-04-012022-06-300001844862us-gaap:CommonStockMember2022-01-012022-06-300001844862us-gaap:CommonStockMember2023-04-012023-06-300001844862us-gaap:CommonStockMember2023-01-012023-06-300001844862us-gaap:RetainedEarningsMember2023-06-300001844862us-gaap:AdditionalPaidInCapitalMember2023-06-300001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001844862us-gaap:RetainedEarningsMember2023-03-310001844862us-gaap:AdditionalPaidInCapitalMember2023-03-310001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-3100018448622023-03-310001844862us-gaap:RetainedEarningsMember2022-12-310001844862us-gaap:AdditionalPaidInCapitalMember2022-12-310001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001844862us-gaap:RetainedEarningsMember2022-06-300001844862us-gaap:AdditionalPaidInCapitalMember2022-06-300001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001844862us-gaap:RetainedEarningsMember2022-03-310001844862us-gaap:AdditionalPaidInCapitalMember2022-03-310001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-3100018448622022-03-310001844862us-gaap:RetainedEarningsMember2021-12-310001844862us-gaap:AdditionalPaidInCapitalMember2021-12-310001844862us-gaap:CommonStockMember2023-06-300001844862us-gaap:CommonStockMember2023-03-310001844862us-gaap:CommonStockMember2022-12-310001844862us-gaap:CommonStockMember2022-06-300001844862us-gaap:CommonStockMember2022-03-310001844862us-gaap:CommonStockMember2021-12-310001844862us-gaap:EmployeeStockOptionMember2023-06-300001844862us-gaap:EmployeeStockOptionMember2023-03-310001844862us-gaap:EmployeeStockOptionMember2022-12-310001844862us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001844862us-gaap:RestrictedStockUnitsRSUMember2023-06-300001844862us-gaap:RestrictedStockUnitsRSUMember2023-03-310001844862us-gaap:RestrictedStockUnitsRSUMember2022-12-310001844862us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001844862sldp:BmwOfNorthAmericaLlcMember2023-04-012023-06-300001844862sldp:BmwOfNorthAmericaLlcMember2023-01-012023-06-300001844862us-gaap:LeaseholdImprovementsMember2023-06-300001844862us-gaap:EquipmentMember2023-06-300001844862us-gaap:ConstructionInProgressMember2023-06-300001844862sldp:LaboratoryEquipmentMember2023-06-300001844862sldp:FurnitureAndComputerEquipmentMember2023-06-300001844862us-gaap:LeaseholdImprovementsMember2022-12-310001844862us-gaap:EquipmentMember2022-12-310001844862us-gaap:ConstructionInProgressMember2022-12-310001844862sldp:LaboratoryEquipmentMember2022-12-310001844862sldp:FurnitureAndComputerEquipmentMember2022-12-310001844862sldp:EquityIncentive2014PlanMember2023-04-012023-06-300001844862sldp:EquityIncentive2014PlanMember2023-01-012023-06-300001844862sldp:EquityIncentive2014PlanMember2022-04-012022-06-300001844862sldp:EquityIncentive2014PlanMember2022-01-012022-06-300001844862sldp:BmwOfNorthAmericaLlcMember2023-06-300001844862us-gaap:RetainedEarningsMember2023-01-012023-03-310001844862us-gaap:RetainedEarningsMember2022-04-012022-06-300001844862us-gaap:RetainedEarningsMember2022-01-012022-03-310001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001844862us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001844862sldp:PublicWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001844862sldp:PublicWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-3100018448622021-09-010001844862srt:MinimumMember2023-06-300001844862srt:MaximumMember2023-06-300001844862us-gaap:TrademarksMember2023-06-300001844862sldp:TrademarksPendingMember2023-06-300001844862sldp:PatentsPendingMember2023-06-300001844862us-gaap:TrademarksMember2022-12-310001844862sldp:TrademarksPendingMember2022-12-310001844862sldp:PatentsPendingMember2022-12-310001844862us-gaap:PatentsMember2023-06-300001844862us-gaap:LicensingAgreementsMember2023-06-300001844862us-gaap:LicensingAgreementsMember2022-12-310001844862us-gaap:FairValueMeasurementsRecurringMember2023-03-310001844862us-gaap:FairValueMeasurementsRecurringMember2022-12-310001844862us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-04-012023-06-300001844862us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-06-300001844862us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-01-012022-12-310001844862us-gaap:FairValueMeasurementsRecurringMember2023-04-012023-06-300001844862sldp:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-06-300001844862us-gaap:FairValueMeasurementsRecurringMember2023-01-012023-06-300001844862us-gaap:PropertyPlantAndEquipmentMember2023-04-012023-06-300001844862us-gaap:PropertyPlantAndEquipmentMember2023-01-012023-06-300001844862us-gaap:PropertyPlantAndEquipmentMember2022-04-012022-06-300001844862us-gaap:PropertyPlantAndEquipmentMember2022-01-012022-06-300001844862sldp:OtherCellDevelopmentEquipmentMember2023-06-300001844862sldp:EvCellLineMember2023-06-300001844862sldp:ElectrolyteProductionAndDevelopmentEquipmentMember2023-06-300001844862sldp:OtherCellDevelopmentEquipmentMember2022-12-310001844862sldp:EvCellLineMember2022-12-310001844862sldp:ElectrolyteProductionAndDevelopmentEquipmentMember2022-12-310001844862us-gaap:FairValueMeasurementsRecurringMember2023-06-300001844862sldp:PublicWarrantsMember2023-06-300001844862sldp:PrivatePlacementWarrantsMember2023-06-300001844862sldp:PublicWarrantsMember2022-12-310001844862sldp:PrivatePlacementWarrantsMember2022-12-310001844862us-gaap:WarrantMember2023-06-3000018448622022-06-3000018448622021-12-310001844862us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2023-06-300001844862us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2023-06-300001844862us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2023-06-300001844862us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2023-06-300001844862us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2023-06-300001844862us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2023-06-300001844862us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2022-12-310001844862us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2022-12-310001844862us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2022-12-310001844862us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2022-12-310001844862us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2022-12-310001844862us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2022-12-310001844862us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2022-12-310001844862us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2022-12-310001844862us-gaap:WarrantMember2023-01-012023-06-300001844862sldp:EquityIncentive2021PlanMember2023-01-012023-06-300001844862sldp:EquityIncentive2014And2021PlanMember2023-01-012023-06-300001844862sldp:EmployeeStockPurchasePlan2021Member2023-01-012023-06-300001844862sldp:ContingentlyIssuableCommonStockMember2023-01-012023-06-300001844862us-gaap:WarrantMember2022-01-012022-06-300001844862sldp:EquityIncentive2021PlanMember2022-01-012022-06-300001844862sldp:EquityIncentive2014And2021PlanMember2022-01-012022-06-300001844862us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300001844862us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001844862us-gaap:EmployeeStockMember2023-04-012023-06-300001844862us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001844862us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001844862us-gaap:EmployeeStockMember2023-01-012023-06-300001844862us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001844862us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001844862us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001844862us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001844862us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100018448622023-01-012023-03-310001844862us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100018448622022-01-012022-03-310001844862us-gaap:RetainedEarningsMember2023-04-012023-06-300001844862us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001844862us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000018448622023-06-3000018448622022-12-310001844862sldp:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001844862sldp:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001844862sldp:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001844862sldp:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-04-012023-06-300001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-04-012023-06-300001844862sldp:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-03-310001844862sldp:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-03-3100018448622023-04-012023-06-3000018448622022-04-012022-06-3000018448622022-01-012022-06-300001844862us-gaap:CommonStockMember2023-01-012023-06-300001844862sldp:WarrantsMember2023-01-012023-06-3000018448622023-08-0700018448622023-01-012023-06-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puresldp:Y

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission file number: 001-40284

Graphic

SOLID POWER, INC.

(Exact name of registrant as specified in its charter)

Delaware

   

86-1888095

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

486 S. Pierce Ave., Suite E

Louisville, Colorado

80027

(Address of principal executive offices)

(Zip Code)

(303) 219-0720

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

   

Trading symbol(s)

   

Name of each exchange on which registered

Common stock, par value $0.0001 per share

SLDP

The Nasdaq Stock Market LLC

Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50

SLDPW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

178,390,443 shares of common stock were issued and outstanding as of August 7, 2023.

GLOSSARY OF DEFINED TERMS

Term

Definition

Ah

Ampere hour

BMW

BMW of North America LLC

ESPP

Solid Power, Inc. 2021 Employee Stock Purchase Plan

EV

Battery electric vehicle

EV cells

Prototype cell formats between 60 and 100 Ah

EV line

Our pilot cell production line that is capable of producing cells between 60 and 100 Ah.

Exchange Act

Securities Exchange Act of 1934, as amended

Ford

Ford Motor Company

GAAP

Generally accepted accounting principles in the United States

JDA

Joint development agreement

OEM

Automotive original equipment manufacturers

Q1 Form 10-Q

Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023

Report

This Quarterly Report on Form 10-Q

SEC

Securities and Exchange Commission

Solid Power / the Company / we / us / our

Solid Power, Inc., a Delaware corporation (f/k/a Decarbonization Plus Acquisition Corporation III)

SP2

Our Thornton, CO facility that houses electrolyte development

2022 Form 10-K

Our Annual Report on Form 10-K for the year ended December 31, 2022

2

Cautionary Note Regarding Forward-Looking Statements

This Report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. We have based these forward-looking statements on our current expectations and projections about future events. All statements, other than statements of present or historical fact included in this Report, regarding our future financial performance and our strategy, expansion plans, market opportunity, future operations, future operating results, estimated revenues or losses, projected costs, prospects, plans, and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “continue,” “project,” or the negative of such terms or other similar expressions. These forward-looking statements are subject to known and unknown risks, uncertainties, and assumptions about us that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this Report. We caution you that the forward-looking statements contained herein are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond our control.

In addition, we caution you that the forward-looking statements regarding the Company contained in this Report are subject to the following factors:

risks relating to the uncertainty of the success of our research and development efforts, including our ability to achieve the technological objectives or results that our partners require, and to commercialize our technology in advance of competing technologies;
risks relating to the non-exclusive nature of our original equipment manufacturers and JDA relationships;
our ability to negotiate and execute supply agreements with our partners on commercially reasonable terms;
rollout of our business plan and the timing of expected business milestones;
delays in the construction and operation of production facilities;
our ability to protect our intellectual property, including in jurisdictions outside of the United States;
broad market adoption of EVs and other technologies where we are able to deploy our cell technology and electrolyte material, if developed successfully;
our success in retaining or recruiting, or changes required in, our officers, key employees, including technicians and engineers, or directors;
risks and potential disruptions related to management and board of directors transitions;
changes in applicable laws or regulations;
risks related to technology systems and security breaches;
the possibility that we may be adversely affected by other economic, business or competitive factors, including supply chain interruptions, and may not be able to manage other risks and uncertainties;
risks relating to our status as a research and development stage company with a history of financial losses, and an expectation to incur significant expenses and continuing losses for the foreseeable future;
the termination or reduction of government clean energy and electric vehicle incentives;
changes in domestic and foreign business, market, financial, political and legal conditions; and

3

those factors discussed in “Part I, Item 1A. Risk Factors” in our 2022 Form 10-K and in “Part II, Item 1A. Risk Factors” in our Q1 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC.

We caution you that the foregoing list does not contain all of the risks or uncertainties that could affect the Company.

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, operating results, financial condition and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors, including those described in “Part I, Item 1A. Risk Factors” in our 2022 Form 10-K and “Part II, Item 1A. Risk Factors” in our Q1 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Report. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.

Neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Moreover, the forward-looking statements made in this Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Report to reflect events or circumstances after the date of this Report or to reflect new information or the occurrence of unanticipated events, except as required by law. You should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.

TRADEMARKS

Our logo and trademark appearing in this Report and the documents incorporated by reference herein are our property. This document and the documents incorporated by reference herein contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Report may appear without the ® or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies.

MARKET AND INDUSTRY DATA

We obtained the industry and market data used throughout this Report or any documents incorporated herein by reference from our own internal estimates and research, as well as from independent market research, industry and general publications and surveys, governmental agencies, publicly available information, and research, surveys, and studies conducted by third parties. Internal estimates are derived from publicly available information released by industry analysts and third-party sources, our internal research, and our industry experience and are based on assumptions made by us based on such data and our knowledge of our industry and market, which we believe to be reasonable. In some cases, we do not expressly refer to the sources from which this data is derived. In addition, while we believe the industry and market data included in this Report or any documents incorporated herein by reference is reliable and based on reasonable assumptions, such data involve material risks and other uncertainties and is subject to change based on various factors, including those discussed in the section entitled “Risk Factors.” These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties or by us.

4

INFORMATION ABOUT SOLID POWER

We use our website (www.solidpowerbattery.com) and various social media channels as a means of disclosing information about Solid Power and our products to our customers, investors, and the public (e.g., @SolidPowerInc on Twitter, Solid Power Inc. on LinkedIn, and Solid Power on YouTube). The information posted on our website and social media channels is not incorporated by reference in this Report or in any other report or document we file with the SEC. Further, references to our website URLs are intended to be inactive textual references only. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings, and public conference calls and webcasts. In addition, you may automatically receive e-mail alerts and other information about Solid Power when you enroll your e-mail address by visiting the “Investor Email Alerts” section of our website at https://ir.solidpowerbattery.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Exchange Act are filed with the SEC. These reports and other information we file with the SEC are available free of charge at https://ir.solidpowerbattery.com/financial-information/sec-filings when such reports are available on the SEC’s website.

5

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

Solid Power, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except par value and number of shares)

June 30, 2023

    

(Unaudited)

    

December 31, 2022

Assets

Current Assets

 

  

 

  

Cash and cash equivalents

$

28,439

$

50,123

Marketable securities

192,694

272,957

Contract receivables

 

5,224

 

1,840

Prepaid expenses and other current assets

 

3,494

 

2,888

Total current assets

 

229,851

 

327,808

Property, Plant and Equipment, net

 

95,076

 

82,761

Right-Of-Use Operating Lease Asset, net

7,444

7,725

Right-Of-Use Financing Lease Asset, net

938

922

Other Assets

1,087

1,148

Long-term Investments

222,255

172,974

Intangible Assets, net

 

1,360

 

1,108

Total assets

$

558,011

$

594,446

Liabilities and Stockholders’ Equity

 

 

Current Liabilities

 

 

Accounts payable and other accrued liabilities

8,065

11,326

Current portion of long-term debt

 

 

7

Deferred revenue

 

18

 

4,050

Accrued compensation

 

4,080

 

4,528

Operating lease liabilities, short-term

586

549

Financing lease liability, short-term

308

273

Total current liabilities

 

13,057

 

20,733

Warrant Liabilities

6,791

9,117

Operating Lease Liabilities, Long-Term

8,317

8,622

Financing Lease Liabilities, Long-Term

 

535

 

602

Total liabilities

28,700

39,074

Stockholders’ Equity

 

  

 

  

Common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 178,326,890 and 176,007,184 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively

 

18

 

18

Additional paid-in capital

 

583,034

577,603

Accumulated deficit

 

(50,369)

 

(19,090)

Accumulated other comprehensive loss

(3,372)

(3,159)

Total stockholders’ equity

 

529,311

 

555,372

Total liabilities and stockholders’ equity

$

558,011

$

594,446

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

6

Solid Power, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)

(in thousands, except number of shares and per share amounts)

    

Three Months Ended June 30, 

Six Months Ended June 30, 

2023

    

2022

2023

    

2022

Revenue

$

4,906

$

2,582

$

8,698

$

4,778

Operating Expenses

 

 

Direct costs

6,897

2,987

13,171

5,017

Research and development

14,508

 

8,440

26,156

 

15,101

Selling, general and administrative

5,673

 

5,851

12,862

 

10,670

Total operating expenses

27,078

 

17,278

52,189

 

30,788

Operating Loss

(22,172)

 

(14,696)

(43,491)

 

(26,010)

Nonoperating Income and Expense

 

 

Interest income

4,993

931

9,827

1,171

Change in fair value of warrant liabilities

4,987

27,473

2,325

28,183

Interest expense

(13)

 

(5)

(26)

 

(10)

Total nonoperating income and expense

9,967

 

28,399

12,126

 

29,344

Pretax Income (Loss)

(12,205)

 

13,703

(31,365)

 

3,334

Income tax benefit

 

36

 

13

Net Income (Loss) Attributable to Common Stockholders

$

(12,205)

$

13,667

$

(31,365)

$

3,321

Other Comprehensive Income (Loss)

1,098

(961)

(213)

(1,291)

Comprehensive Income (Loss) Attributable to Common Stockholders

$

(11,107)

$

12,706

$

(31,578)

$

2,030

Basic and diluted earnings (loss) per share

$

(0.07)

$

0.08

$

(0.18)

$

0.02

Weighted average shares outstanding – basic

178,063,573

 

174,128,230

177,502,037

 

173,266,760

Weighted average shares outstanding – diluted

178,063,573

 

174,703,533

177,502,037

 

173,566,001

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

7

Solid Power, Inc.

Condensed Consolidated Statement of Stockholders’ Equity (Unaudited)

(in thousands, except number of shares)

Common Stock

Additional

Accumulated

Accumulated Other

Total Stockholders’

    

Shares

    

Amount

    

paid-in capital

    

deficit

    

Comprehensive Loss

    

Equity

Balance as of December 31, 2022

176,007,184

$

18

$

577,603

$

(19,090)

$

(3,159)

$

555,372

Net loss

 

 

 

(19,158)

 

(19,158)

Stock options exercised

 

1,679,954

 

150

 

 

150

Stock-based compensation expense

 

 

2,222

 

 

2,222

Unrealized gain on marketable securities

885

885

Balance as of March 31, 2023

177,687,138

$

18

$

579,975

$

(38,248)

$

(2,274)

$

539,471

Net loss

 

 

 

(12,205)

 

(12,205)

Shares issued under ESPP

129,928

214

214

Withholding of employee taxes related to stock-based compensation

(111)

84

(27)

Shares issued for vested RSUs

163,148

Stock options exercised

 

346,676

 

33

 

 

33

Stock-based compensation expense

 

 

2,923

 

 

2,923

Unrealized loss on marketable securities

(1,098)

(1,098)

Balance as of June 30, 2023

178,326,890

$

18

$

583,034

$

(50,369)

$

(3,372)

$

529,311

Common Stock

Additional

Accumulated

Accumulated Other

Total Stockholders’

    

Shares

    

Amount

    

paid-in capital

    

deficit

    

Comprehensive Loss

    

Equity

Balance as of December 31, 2021

167,557,988

$

17

$

568,183

$

(9,535)

$

$

558,665

Net loss

 

 

 

(10,344)

 

(10,344)

Transaction fees

(12)

(12)

Stock options exercised

 

6,212,964

 

270

 

 

270

Stock-based compensation expense

 

 

1,596

 

 

1,596

Unrealized loss on marketable securities

(330)

(330)

Balance as of March 31, 2022

173,770,952

$

17

$

570,037

$

(19,879)

$

(330)

$

549,845

Net income (loss)

 

13,667

13,667

Withholding of employee taxes related to stock-based compensation

(58)

(58)

Shares issued for the vesting of RSUs

20,672

Stock options exercised

 

656,180

163

163

Stock-based compensation expense

 

2,314

2,314

Unrealized loss on marketable securities

 

(961)

(961)

Balance as of June 30, 2022

174,447,804

$

17

$

572,456

$

(6,212)

$

(1,291)

$

564,970

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

8

Solid Power, Inc.

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

Six Months Ended June 30, 

    

2023

    

2022

Cash Flows from Operating Activities

 

Net income (loss)

$

(31,365)

$

3,321

Adjustments to reconcile net income (loss) to net cash and cash equivalents from operating activities:

 

Depreciation and amortization

4,906

 

1,782

Amortization of right-of-use assets

372

16

Stock compensation expense

5,145

 

3,910

Deferred taxes

 

13

Change in fair value of warrant liabilities

(2,325)

(28,183)

Amortization of premiums and accretion of discounts on marketable securities

(5,518)

Change in operating assets and liabilities that provided (used) cash and cash equivalents:

 

Contract receivable

(3,383)

 

(1,202)

Prepaid expenses and other assets

(188)

 

744

Accounts payable and other accrued liabilities

(297)

 

(4,261)

Deferred revenue

(4,032)

 

(286)

Accrued expenses

649

 

1,000

Lease liabilities

(268)

188

Net cash and cash equivalents used in operating activities

(36,304)

 

(22,958)

Cash Flows from Investing Activities

 

Purchases of property, plant and equipment

(21,184)

 

(30,957)

Purchases of marketable securities and long-term investments

(174,400)

 

(212,792)

Proceeds from sales of marketable securities

210,329

54,819

Purchases of intangible assets

(259)

 

(228)

Net cash and cash equivalents provided by (used in) investing activities

14,486

 

(189,158)

Cash Flows from Financing Activities

 

Payments of debt

(7)

 

(71)

Proceeds from exercise of stock options

184

 

354

Proceeds from issuance of common stock under ESPP

214

Receivable for exercise of stock options

79

Cash paid for withholding of employee taxes related to stock-based compensation

(111)

(58)

Payments on finance lease liability

(146)

(20)

Transaction costs

(12)

Net cash and cash equivalents provided by financing activities

134

272

Net (decrease) in cash and cash equivalents

(21,684)

(211,844)

Cash and cash equivalents at beginning of period

50,123

513,447

Cash and cash equivalents at end of period

28,439

301,603

Cash paid for interest

$

26

$

5

Accrued capital expenditures

$

3,591

$

8,146

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

9

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 – Nature of Business

Solid Power, Inc. (the “Company”) is developing solid state battery technology to enable the next generation of batteries for the fast-growing EV and other markets. The Company’s planned business model is to sell its sulfide-based solid electrolyte and to license its solid-state cell designs and manufacturing process.

Note 2 – Significant Accounting Policies

The significant accounting policies followed by the Company are set forth in Note 2 – Significant Accounting Policies to the Company’s financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”) and are supplemented by the Notes to the Condensed Consolidated Financial Statements (Unaudited) (the “Notes”) included in this Quarterly Report on Form 10-Q for the period ended June 30, 2023 (this “Report”). The financial statements included in this Report (including the Notes) should be read in conjunction with the 2022 Form 10-K.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared on the basis of generally accepted accounting principles in the United States (“GAAP”). The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from those estimates. All dollar amounts presented herein are in U.S. dollars and are in thousands, except par value, share and per share amounts.

The accompanying unaudited condensed consolidated financial statements include accounts of the Company and its wholly owned subsidiary, Solid Power Operating, Inc. All intercompany balances and transactions have been eliminated in consolidation. Additionally, certain prior period amounts have been reclassified to conform to current period presentation in the accompanying unaudited condensed consolidated financial statements.

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), followed by other related ASUs that provided targeted improvements and additional practical expedient options. On January 1, 2022, the Company adopted the standards under Topic 842 using the modified retrospective method and elected a number of the practical expedients in its implementation of Topic 842. The key change that affected the Company relates to accounting for operating leases for which it is the lessee that were historically off-balance sheet.

Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. ASU 2016-13 also provides updated guidance regarding the impairment of available-for-sale debt securities and includes additional disclosure requirements. The Company adopted this guidance as of January 1, 2022.

The Company regularly reviews its available-for-sale marketable securities and evaluates the current expected credit losses by considering factors such as any changes in credit ratings, historical experience, market data, issuer-specific factors, and current economic conditions. Based on this analysis, any allowance for credit losses is immaterial and would be recorded as a reduction to the carrying value of the asset.

The Company reviews its receivable aging on an individual customer level, considering collectability of cash flows based on the risk of past events, current conditions, and forward-looking information. The Company establishes allowances for bad debts equal to the estimable portions of accounts receivable for which failure to collect is expected to occur. Allowances for doubtful accounts are recorded as reductions to the carrying values of the related receivables. To date, the Company has not recorded an allowance for doubtful accounts.

10

Note 3 – Property, Plant and Equipment

Property, plant and equipment are summarized as follows:

    

June 30, 2023

    

December 31, 2022

Commercial production equipment

$

25,454

$

21,595

Laboratory equipment

7,554

3,278

Leasehold improvements

 

45,581

 

27,996

Furniture and computer equipment

 

1,634

 

1,482

Construction in progress

 

31,317

 

40,036

Total cost

 

111,540

 

94,387

Accumulated depreciation

 

(16,464)

 

(11,626)

Net property and equipment

$

95,076

$

82,761

Depreciation expenses for dedicated laboratory equipment and commercial production equipment are charged to research and development. The other depreciation expenses are included in the Company’s overhead and are allocated across operating expenses on the accompanying Condensed Consolidated Statements of Operations based on Company personnel costs incurred.

Depreciation expense related to property, plant, and equipment are summarized as follows:

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

    

2022

2023

    

2022

Depreciation expense

$

2,639

$

1,026

$

4,898

$

1,777

In 2022, the Company expanded its cell production capabilities through the construction of a second dry room and installation of a second cell pilot production line at its Louisville, Colorado facility, which is designed to produce larger format solid-state battery cells for the automotive qualification process.

The Company expanded its electrolyte production at its facility in Thornton, Colorado. Scaling this production will allow it to produce larger quantities of electrolyte material required to feed cell-production lines and continue research and development efforts. The Company began producing electrolyte at this facility in 2023 and has placed portions of the facility into service.

June 30, 2023

December 31, 2022

Construction in progress

EV cell line (SP1)

$

1,083

$

2,010

Other cell development equipment (SP1)

2,703

2,206

Electrolyte production and development equipment (SP2)

27,531

35,820

Note 4 – Intangible Assets

Intangible assets of the Company are summarized as follows:

    

June 30, 2023

    

December 31, 2022

Gross Carrying

Accumulated

Gross Carrying

Accumulated

    

Amount

    

Amortization

    

Amount

    

Amortization

Intangible assets:

Licenses

$

149

$

(56)

$

149

$

(51)

Patents

72

(3)

Patents pending

 

1,168

 

 

984

 

Trademarks

13

9

Trademarks pending

 

17

 

 

17

 

Total amortized intangible assets

$

1,419

$

(59)

$

1,159

$

(51)

11

Amortization expense for intangible assets is summarized as follows:

Three Months Ended June 30, 

Six Months Ended June 30, 

 

    

2023

    

2022

2023

    

2022

 

Amortization expense

$

3

$

2

$

8

$

5

Useful lives of intangible assets range from three to 20 years. Amortization expenses are allocated ratably across operating expenses on the accompanying condensed consolidated statements of operations.

Note 5 – Fair Value Measurements

The carrying amounts of certain financial instruments, such as cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued liabilities, approximate fair value due to their relatively short maturities.

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

As of June 30, 2023 and December 31, 2022, the Company’s financial assets and liabilities measured and recorded at fair value on a recurring basis were classified within the fair value hierarchy as follows:

June 30, 2023

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

Commercial Paper

$

137,072

$

$

$

137,072

Corporate Bonds

$

216,390

$

$

$

216,390

Government Bonds

$

61,487

$

$

$

61,487

U.S. Treasuries

 

 

Liabilities

Public Warrants

$

3,932

$

$

$

3,932

Private Placement Warrants

$

$

2,859

$

$

2,859

December 31, 2022

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

Commercial Paper

$

165,179

$

$

$

165,179

Corporate Bonds

$

227,957

$

$

$

227,957

Government Bonds

$

42,865

$

$

$

42,865

U.S. Treasuries

 

9,930

 

9,930

Liabilities

Public Warrants

$

4,900

$

$

$

4,900

Private Placement Warrants

$

$

4,217

$

$

4,217

The change in fair value of the Company’s marketable securities and long-term investments are included in other comprehensive loss. There were no transfers in and out of Level 3 fair value hierarchy during the three or six months ended June 30, 2023 or year ended December 31, 2022. For the three and six months ended June 30, 2023, the Company purchased $174,400 of marketable securities.

Fair Value of Warrants

The fair value of the Private Placement Warrants (defined below) has been estimated using a Black-Scholes model as of June 30, 2023 and December 31, 2022 Consolidated Balance Sheet dates. The fair value of the Public Warrants (defined below) has been measured based on the quoted price of such warrants on the Nasdaq Stock Market, a Level 1 input. The estimated fair value of the Private Placement Warrants is determined using Level 2 inputs. Inherent in a Black-Scholes model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. Material increases (or decreases) in any of those inputs may result in a significantly higher (or lower) fair value measurement. The Company estimates the volatility of its Private Placement Warrants based on implied volatility from the Company’s Public Warrants and from historical volatility of select peer

12

companies’ common stock that matches the expected remaining life of the Warrants (defined below). The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve for a maturity similar to the expected remaining life of the Warrants. The expected life of the Warrants is assumed to be equivalent to their remaining contractual term. The dividend yield is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 2 inputs used in the recurring valuation of the Private Placement Warrants as of their measurement dates:

    

June 30, 2023

    

December 31, 2022

 

Exercise Price

$

11.50

$

11.50

Stock Price

$

2.54

$

2.54

Volatility

 

70.0

%  

 

71.3

%

Term

 

3.44

 

3.94

Risk-free rate

 

4.32

%  

 

4.03

%

The following table provides a reconciliation of the Public Warrants measured at fair value using Level 1 directly observable inputs and Private Placement Warrants measured at fair value using Level 2 directly or indirectly observable inputs:

Public Warrants

Private Placement Warrants

    

Level 1 Fair Value

    

Level 2 Fair Value

December 31, 2022

$

0.42

$

0.55

Change in fair value

$

0.04

$

0.31

March 31, 2023

$

0.46

$

0.86

Change in fair value

$

(0.15)

$

(0.43)

June 30, 2023

$

0.31

$

0.43

The following tables provides a reconciliation of the June 30, 2023 three and six month change in fair value for the Public Warrants and Private Placement Warrants:

Three months change in

Warrant Class

    

Level

    

Warrants

    

March 31, 2023

    

fair value

    

June 30, 2023

Public Warrants

 

1

 

12,684,423

$

5,576

$

(1,644)

$

3,932

Private Placement Warrants

 

2

 

6,648,880

$

6,203

$

(3,343)

$

2,860

Total

 

  

 

19,333,303

$

11,779

$

(4,987)

$

6,792

Six months change in

Warrant Class

    

Level

    

Warrants

    

December 31, 2022

    

fair value

    

June 30, 2023

Public Warrants

 

1

 

12,684,423

$

4,900

$

(968)

$

3,932

Private Placement Warrants

 

2

 

6,648,880

$

4,217

$

(1,357)

$

2,860

Total

 

  

 

19,333,303

$

9,117

$

(2,325)

$

6,792

Note 6 – Warrant Liabilities

As of June 30, 2023 and December 31, 2022, there were 12,684,423 and 11,666,636 publicly traded warrants (“Public Warrants”) and 6,648,880 and 7,666,667 private placement warrants (“Private Placement Warrants,” and together with the Public Warrants, “Warrants”) outstanding, respectively. Each whole Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to customary adjustments. Only whole Warrants are exercisable. The Warrants became exercisable on January 7, 2022 and will expire on December 8, 2026.

None of the Private Placement Warrants are redeemable by the Company so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees.

The Warrants were initially measured at fair value upon closing of the transactions contemplated by the Business Combination Agreement and Plan of Reorganization, dated June 15, 2021 by and among the Company, DCRC Merger Sub, Inc., and Solid Power Operating, Inc., as amended, for $101,253 and subsequently re-measured at each reporting period. The Public Warrants were allocated a portion of the proceeds from the issuance of the units of common stock and one-third warrants in Decarbonization Plus Acquisition Corporation III’s initial public offering equal to their fair value. The Company recognized a gain in connection with

13

changes in the fair value of warrant liabilities of $4,987 and $2,325 for the three and six months ending June 30, 2023 and $27,473 and $28,183 for the three and six months ending June 30, 2022, respectively.

There have been no changes to our Public or Private Placement Warrants, including redemption terms disclosed in our 2022 Form 10-K.

Note 7 – Stockholders’ Equity

Common Stock

Stock options exercised for Common Stock, shares issued under the Solid Power, Inc. 2021 Employee Stock Purchase Plan (“ESPP”), and shares issued upon vesting of RSUs for the three and six months ended June 30, 2023 and 2022 are summarized in the table below:

Three months ended June 30, 

Six months ended June 30, 

    

2023

    

2022

2023

    

2022

Stock options exercised

346,676

656,180

2,026,630

6,869,144

Shares issued under ESPP

129,928

129,928

Shares issued upon vesting of RSUs

163,148

20,672

163,148

20,672

Cash received from stock options exercised under the Solid Power, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) for the six months ended June 30, 2023 and 2022 was $184 and $354, respectively. Cash received from stock options exercised under the 2014 Plan for the three months ended June 30, 2023 and 2022 was $34 and $84, respectively.

Cash received from shares issued under the ESPP for the six months ended June 30, 2023 and 2022 was $214 and $0, respectively. Cash received from shares issued under the ESPP for the three months ended June 30, 2023 and 2022 was $214 and $0, respectively.

Note 8 – Stock Based Compensation

There have been no changes to our equity incentive plans, Employee Stock Purchase Plan, or accounting methodology for stock based compensation, as disclosed in our 2022 Form 10-K.

The fair value of stock options and Restricted Stock Units (“RSUs”) issued to employees and directors is recognized as compensation expense over the period of service that generally coincides with the vesting period of the award. The Company allocated compensation ratably across Operating Expenses. When calculating the amount of annual compensation expense, the Company has elected not to estimate forfeitures and instead accounts for forfeitures as they occur.

For the three and six months ended June 30, 2023, the Company recognized compensation costs totaling:

Three months ended June 30, 

Six months ended June 30, 

    

2023

    

2022

2023

    

2022

Equity-based compensation costs related to RSUs

$

954

$

514

$

1,589

$

514

Equity-based compensation costs related to stock options

 

1,889

 

1,800

 

3,476

 

3,396

Equity-based compensation costs related to ESPP

80

80

Total equity-based compensation costs

$

2,923

$

2,314

$

5,145

$

3,910

Unrecognized future compensation cost as of

34,327

25,316

14

The following table summarizes our award activity for RSUs and stock options for the three and six months ended June 30, 2023:

    

RSUs

Stock Options

Balance at December 31, 2022

1,057,980

 

25,998,172

Granted

1,797,034

3,272,873

Vested or Exercised

(1,679,954)

Forfeited

(88,441)

(1,494,020)

Balance at March 31, 2023

2,766,573

26,097,071

Granted

1,753,207

1,904,016

Vested or Exercised

(215,553)

(346,676)

Forfeited

(47,181)

(466,635)

Outstanding at June 30, 2023

4,257,046

27,187,776

Stock Options

The fair value of each stock option grant during the six months ended June 30, 2023 and 2022 was estimated on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions used:

    

Six months ended June 30, 

 

    

2023

 

2022

 

Approximate riskfree rate

 

4.17

%

2.84

%

Volatility

 

46.91

%

44.69

%

Average expected life (years)

 

6 years

6 years

Dividend yield

 

%

%

Weightedaverage grant date fair value

$

2.80

$

7.26

Estimated fair value of total stock options granted

$

7,815

$

5,659

Note 9 – Earnings (Loss) Per Share

Basic earnings (loss) per share represents net income (loss) attributable to common stock divided by the basic weighted average number of common stock outstanding during the period.

Due to the net loss for the three and six months ended June 30, 2023, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. Due to the net income for the three and six months ended June 30, 2022, diluted earnings per share was computed with consideration to potentially dilutive instruments. Warrants outstanding in 2023 and 2022 were not included in the computation of diluted earnings per share because the Warrant’s exercise price for the period was greater than the average market price of the common stock.

The table below sets forth the basic and diluted earnings (loss) per share calculation for the three and six months ended June 30, 2023 and 2022.

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

2022

2023

2022

Net income (loss) attributable to common stockholders

$

(12,205)

$

13,667

$

(31,365)

$

3,321

Weighted average shares outstanding – basic

178,063,573

174,128,230

177,502,037

173,266,760

Weighted average shares outstanding – diluted

178,063,573

174,703,533

177,502,037

173,566,001

Basic and diluted earnings (loss) per share

$

(0.07)

$

0.08

$

(0.18)

$

0.02

15

As of the three and six months ended June 30, 2023, potentially dilutive securities excluded from the diluted loss per share calculation are as illustrated in the table below. Additionally, for the three and six months ended June 30, 2022, potentially dilutive securities included from the diluted earnings per share calculation are as follows (in shares):

Six Months Ended June 30, 

2023

    

2022

Warrants

19,333,303

 

19,333,303

2014 & 2021 Equity Incentive Plan - Stock Options

25,892,666

 

27,161,312

2021 Equity Incentive Plan - RSUs

2,474,393

 

1,674,284

2021 Employee Stock Purchase Plan - Common Stock

46,352

Contingently Issuable Common Stock

59,055

Total potentially dilutive securities

47,805,769

48,168,899

Note 10 – Leases

The Company leases its two facilities and certain equipment. Fixed rent generally escalates each year, and the Company is responsible for a portion of the landlords’ operating expenses such as property tax, insurance, and common area maintenance.

The Company’s facility in Louisville, Colorado, is under a noncancelable operating lease with a maturity date in September 2029. In 2022, the Company amended the lease to incorporate a prior subleased space into the base lease and extend the term of the lease. The Company has the right to renew this lease for an additional five-year period.

On September 1, 2021, the Company entered into an industrial operating lease agreement for its facility in Thornton, Colorado, with the initial term through March 31, 2029. Under this operating lease, the Company has one option to renew for five years, which has been included in the calculation of lease liabilities and right-of-use assets at the adoption date of the lease accounting standard on January 1, 2022, as the exercise of the option was reasonably certain. As the renewal rent has not been negotiated, the Company used an estimated rent rate which approximated the fair market rent at adoption of ASC 842 on January 1, 2022 for the extension period.

The Company has certain equipment leases classified as finance leases as of June 30, 2023.

The Company’s leases do not have any contingent rent payments and do not contain residual value guarantees.

The components of lease expense are as follows:

    

Three Months Ended

    

Six Months Ended

    

June 30, 2023

    

June 30, 2023

Finance lease costs:

 

  

 

  

Amortization of right-of-use assets

$

47

$

91

Interest on lease liabilities

 

13

 

25

Operating lease costs

 

290

 

580

Total lease expense

$

350

$

696

The components of cash flow information related to leases are as follows:

    

Three Months Ended

    

Six Months Ended

    

June 30, 2023

    

June 30, 2023

Operating outgoing cash flows – finance lease

$

14

$

26

Financing outgoing cash flows – finance lease

 

74

 

141

Operating outgoing cash flows – operating lease

 

283

 

567

Right-of-use assets obtained in exchange for new finance lease liabilities:

79

89

Right-of-use assets obtained in exchange for new operating lease liabilities:

16

    

June 30, 2023

 

Finance lease

 

  

Weighted-average remaining lease term – finance lease (in years)

 

2.98

Weighted-average discount rate – finance lease

 

6.2

%

Operating lease

 

  

Weighted-average remaining lease term – operating lease (in years)

 

9.71

Weighted-average discount rate – operating lease

 

6.9

%

As of June 30, 2023, future minimum payments during the next five years and thereafter are as follows:

Fiscal year

    

Finance Lease

    

Operating Lease

2023 (remaining six months)

$

174

$

571

2024

349

1,173

2025

234

1,210

2026

109

1,248

2027

37

1,288

2028

16

1,329

Thereafter

5,244

Total

919

12,063

Less present value discount

77

3,158

Total lease liabilities

$

842

$

8,905

Note 11 – Related Party Transactions

During the three and six months ended June 30, 2023, the Company recognized $3,470 and $6,470, respectively, of revenue related to the BMW joint development agreement. As of June 30, 2023 the Company recorded $2,477 of accounts receivable related to the BMW joint development agreement.

Note 12 – Income Taxes

The Company’s effective tax rate was 0.00% and 0.27% for the three months ended June 30, 2023 and 2022, respectively, and 0.00% and 0.49% for the six months ended June 30, 2023 and 2022, respectively. The change in the effective tax rate between periods was due to the Company was being in a full valuation allowance for the three and six months ended June 30, 2023.

Note 13 – Contingencies

In the normal course of business, the Company may be party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the consolidated financial statements and related notes thereto included elsewhere in this Report. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs, and expected performance. For additional discussion, see “Cautionary Note Regarding Forward-Looking Statements” above. The forward-looking statements are dependent upon events, risks, and uncertainties that may be outside of our control. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed elsewhere in this Report, under Part I, Item 1A. “Risk Factors” of our 2022 Form 10-K, and under “Part II, Item 1A. Risk Factors” in our Q1 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. Unless indicated otherwise, the following discussion and analysis of results of operations and financial condition and liquidity relates to our current continuing operations and should be read in conjunction with the consolidated financial statements and notes thereto of this Report and our 2022 Form 10-K. We do not undertake, and expressly disclaim, any obligation to publicly update any forward-looking statements, whether as a result of new information, new developments, or otherwise, except to the extent that such disclosure is required by applicable law.

17

Overview

We are developing solid state battery technologies to enable the next generation of rechargeable batteries for the fast-growing EV and other markets.

Our core technology is our proprietary sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in conventional lithium-ion batteries. We believe that our electrolyte material can enable extended driving range, longer battery life, improved safety, and lower costs compared to conventional lithium-ion.

We also are designing and developing solid state cells that utilize our electrolyte in the cathode, anode, and separator layers. We currently produce 0.2 Ah, 2 Ah, 20 Ah, and EV cells on two pilot lines using established manufacturing processes.

We have partnered with industry leaders, including Ford, BMW, and SK On Co., Ltd. We are working closely with each of these partners to refine and validate our cell designs and electrolyte material with the ultimate goal to commercialize our technologies. Our business model – selling our electrolyte to cell manufacturers and licensing our cell designs and manufacturing processes – distinguishes us from many of our competitors who plan to be commercial battery manufacturers. Ultimately, we endeavor to be a leading producer and distributor of sulfide-based solid electrolyte material for powering both EVs and other applications. Since we do not intend to commercially produce battery cells, we expect to invest less than other development-stage battery companies that plan to commercially manufacture their own cell designs and construct battery production facilities.

The products we currently make are in the development stage and require continued development and validation before we can commercialize either our electrolyte or cell technology.

Recent Business Highlights

SP2 commenced electrolyte powder production in April, began scaling production, and is meeting internal performance and quality targets.
Continued execution on JDAs and extended JDA with Ford.
Received positive feedback from industry leaders on initial electrolyte powder sampling activities.
EV cell production increased and improved 20 Ah cell yields, keeping the company on track for 2023 delivery of A-sample EV cells to partners and delivery of EV cells to BMW for demo car program.
Second half of 2023 is focused on continuing electrolyte scaling and sampling, optimizing cell production processes, improving cell performance, and delivering cells to partners.
Appointed John Van Scoter as President and Chief Executive Officer.

Key Factors Affecting Operating Results

We are a research and development-stage company and have not generated significant revenue through the sale of our electrolyte or licensing of our cell designs. Our ability to commercialize our products depends on several factors that present significant opportunities for us but also pose material risks and challenges, including those discussed in “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements,” appearing in this Report, which are incorporated by reference.

Prior to reaching commercialization, we must test and validate our products to ensure they meet the performance and safety requirements of our customers. We also will have to negotiate licensing and supply contracts with our customers on terms and conditions that are mutually acceptable. We will need to scale production of our electrolyte material to satisfy anticipated demand. All of these factors will take time and affect our operating results. Since many factors are difficult to quantify, our actual operating results may be different than we currently anticipate.

Our revenue generated to date has primarily come from research and development performance on government contracts and research and development licensing activities. We have deployed and are deploying substantial capital to expand our production

18

capabilities and engage in research and development programs. We also continue to incur significantly more administrative expenses as a publicly traded company.

In addition to meeting our development goals and reaching commercialization, future growth and demand for our products will be highly dependent upon market adoption of EVs. The market for new energy vehicles is still rapidly evolving due to emerging technologies, competitive pricing, government regulation and industry standards, and changing consumer demands and behaviors.

Basis of Presentation

We currently conduct our business through one operating segment. As a research and development company with no commercial operations, our activities to date have been limited and were conducted primarily in the United States. Our historical results are reported under GAAP and in U.S. dollars.

Results of Operations

Comparison of the Three and Six Months Ended June 30, 2023 to the Three and Six Months Ended June 30, 2022

During the three and six months ended June 30, 2023, we expanded and accelerated our development efforts through increased capital and operational investments. We continued to invest in talent while expanding our facilities, production equipment, and capabilities. We expect to continue to increase our spending in all operational areas through the remainder of 2023 in order to execute our development strategy.

The following table is a consolidated summary of our operating results for the periods indicated:

Three Months Ended June 30, 

 

Six Months Ended June 30, 

 

(in thousands)

    

2023

    

2022

    

Change

    

%

 

2023

    

2022

    

Change

    

%

 

Revenue

$

4,906

$

2,582

$

2,324

90

%

$

8,698

$

4,778

$

3,920

82

%

Operating Expenses

 

  

 

 

  

 

  

Direct costs

6,897

2,987

 

3,910

 

131

%

 

13,171

5,017

 

8,154

 

163

%

Research and development

14,508

 

8,440

 

6,068

 

72

%

 

26,156

15,101

 

11,055

 

73

%

Selling, general and administrative

5,673

 

5,851

 

(178)

 

(3)

%

 

12,862

10,670

 

2,192

 

21

%

Total operating expenses

27,078

 

17,278

 

9,800

 

57

%

 

52,189

30,788

 

21,401

 

70

%

Operating Loss

(22,172)

 

(14,696)

 

(7,476)

 

(51)

%

 

(43,491)

(26,010)

 

(17,481)

 

(67)

%

Nonoperating Income and Expense

 

  

 

  

 

 

  

 

  

Interest income

4,993

931

 

4,062

 

436

%

 

9,827

1,171

 

8,656

 

739

%

Change in fair value of warrant liabilities

4,987

27,473

(22,486)

(82)

%

2,325

28,183

(25,858)

(123)

%

Interest expense

(13)

(5)

 

(8)

 

160

%

 

(26)

(10)

 

(16)

 

160

%

Total nonoperating income and expense

9,967

 

28,399

$

(18,432)

 

(65)

%

$

12,126

29,344

$

(17,218)

 

(59)

%

Pretax Income (Loss)

(12,205)

 

13,703

(25,908)

NM

(31,365)

3,334

(34,699)

NM

Income tax benefit

 

36

 

(36)

 

NM

 

13

 

(13)

 

NM

Net Income (Loss)

$

(12,205)

$

13,667

 

(25,872)

 

NM

 

(31,365)

$

3,321

 

(34,686)

 

NM

Net Income (Loss) Attributable to Common Stockholders

$

(12,205)

$

13,667

$

(25,872)

 

NM

$

(31,365)

$

3,321

$

(34,686)

 

NM

Other Comprehensive Income (Loss)

1,098

(961)

2,059

 

NM

 

(213)

(1,291)

1,078

 

NM

Comprehensive Income (Loss) Attributable to Common Stockholders

$

(11,107)

$

12,706

$

(23,813)

 

NM

$

(31,578)

$

2,030

$

(33,608)

 

NM

NM = Not meaningful

19

The key factors driving our results of operations for the three and six months ended June 30, 2023, including our increased operating loss as compared to the corresponding periods in 2022, were as follows:

Revenue and direct costs – revenue and related direct costs from the execution of our JDAs drove the overall increase for the periods, while revenue and direct costs from performance on government contracts decreased slightly. We expect revenue and related direct costs to increase in the second half of 2023 as we execute on JDA deliverables and continue to provide samples to third parties and potential customers.
Research and development – our research and development costs increased for the periods primarily as a result of increased labor and material costs as we expanded the development efforts of our battery cells and electrolyte material. We expect our development costs to continue to increase as we continue to accelerate both the pace and scope of our development efforts.
Selling, general and administrative – our selling, general and administrative costs decreased in the three months ended June 30, 2023 primarily due to reduced use of outside professional services and increased in the six months ended June 30, 2023 primarily due to additional planned hiring, and workforce development and training, as we have increased our headcount to over 250 people, as well as enterprise resource planning system costs and implementation efforts.
Operating expenses – non-cash stock compensation costs for the periods increased across direct costs, research and development costs, and selling, general and administrative expenses related to our increased headcount.
Nonoperating income – our nonoperating income decreased for the periods primarily due to loss on fair value adjustment of warrant liabilities, partially offset by strategic cash investments in A-rated investments, which increased both our interest income and other income.

Liquidity and Capital Resources

Sources of Liquidity

Our sources of cash have historically been primarily derived from the sale of equity, with a small portion coming from performance on government contracts and commercial revenues.

As of June 30, 2023 and December 31, 2022, we had total liquidity, as set forth below:

(in thousands)

    

June 30, 2023

December 31, 2022

Cash and cash equivalents

$

28,439

$

50,123

Marketable securities

 

192,694

 

272,957

Long-term investments

 

222,255

 

172,974

Total liquidity

$

443,388

$

496,054

Short-Term Liquidity Requirements

We anticipate that our most significant capital expenditures for the remainder of 2023 will relate to finishing construction of our electrolyte production and development facility. In addition, our short-term liquidity requirements include operating and capital expenses needed to further our technology development programs. We expect to fund our short-term liquidity requirements through our cash on hand and other liquid assets.

Long-Term Liquidity Requirements

We believe that our cash on hand is sufficient to meet our operating cash needs (including expenditures for the increased pace and scope of development as well as increased public company costs) and working capital and capital expenditure requirements for a period of at least the next 12 months and longer term until we generate adequate cash flows from licensing activities and/or electrolyte sales.

20

We may, however, need additional cash if there are material changes to our business conditions or other developments, including changes to our operating plan, development progress, delays in negotiations with OEMs, cell manufacturers, or other suppliers, market adoption of EVs, supply chain challenges, competitive pressures, inflation, and regulatory developments. To the extent that our resources are insufficient to satisfy our cash requirements, we may need to seek additional equity or debt financing. We also may opportunistically seek to enhance our liquidity through equity or debt financing, if such financing becomes available to us on terms that we consider favorable. If the financing is not available, or if the terms of financing are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, which may adversely affect our development, business, operating results, financial condition, and prospects.

Cash Flows

The following table summarizes our cash flows from operating, investing, and financing activities for the periods presented:

Six Months Ended June 30, 

(in thousands)

    

2023

    

2022

Net cash used in operating activities

$

(36,304)

$

(22,958)

Net cash provided by (used in) investing activities

$

14,486

$

(189,158)

Net cash provided by financing activities

$

134

$

272

Cash used in operating activities:

Cash used in operating activities increased from June 30, 2022 to 2023. The increase was primarily attributable to our operating loss, which was driven by continued increase in research and development costs and selling, general and administrative expenses. We continue to expect cash used in operating activities to increase as we accelerate both the pace and scope of our development efforts and work to achieve commercialization of our products. We continue to anticipate increased expenditures for research and development and selling, general and administrative functions to support growth of our development efforts. In addition, we expect to incur increased operating expenses in the second half of 2023 as we execute on BMW JDA deliverables.

Cash flows provided by (used in) investing activities:

Cash provided by investing activities increased from June 30, 2022 to 2023 primarily due to the net effect of increased purchase and sales of marketable securities partially offset by increases in capital expenditures and patent investments. Capital expenditures were primarily for custom manufacturing equipment in connection with our expansion of electrolyte production capabilities. We expect cash used in investing activities to increase as we finalize the build out of our electrolyte production facility and increase its production capabilities, and as we increase our electrolyte production scale. Each of our locations will continue to require investment in specialized equipment to facilitate the manufacturing process of our electrolyte material and battery cells. As our production processes are scaled in the future, especially with respect to our electrolyte material, we expect capital expenditures to increase.

Cash flows provided by financing activities:

Net cash provided by financing activities for the six months ended June 30, 2023 and 2022 was primarily from the cash exercise of stock options and proceeds from the sale of common stock under the ESPP.

Off-Balance Sheet Arrangements

We are not a party to any off-balance sheet arrangements, as defined under SEC rules.

Critical Accounting Estimates

Except as discussed in Note 2 of our unaudited financial statements included in this Report, there were no significant and material changes in our critical accounting policies and use of estimates during the three and six months ended June 30, 2023, as compared to those disclosed in “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” in our 2022 Form 10-K.

21

Recent Accounting Pronouncements

See Note 2 to our audited financial statements included in our 2022 Form 10-K for more information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined in Rule 12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In designing and evaluating our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired controls. As required by Rule 13a-15(b) under the Exchange Act, our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2023. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this Report, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the three months ended June 30, 2023 covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Item 1A. Risk Factors

Our business, prospects, reputation, results of operations and financial condition, as well as the price of our common stock and warrants, can be affected by a number of factors, whether currently known or unknown, including those described in “Part I, Item 1A. Risk Factors” of our 2022 Form 10-K and “Part II, Item 1A. Risk Factors” of our Q1 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. When any one or more of these risks materialize from time to time, our business, reputation, results of operations and financial condition, as well as the price of our common stock and warrants, can be materially and adversely affected. There have been no material changes to our risk factors since our Q1 Form 10-Q.

22

Item 6. Exhibits

Incorporated by Reference

Exhibit

Number

Description

Schedule Form

File Number

Exhibit/Annex

Filing Date

2.1

Business Combination Agreement and Plan of Reorganization, dated as of June 15, 2021, by and among the Company, DCRC Merger Sub, Inc., and Solid Power Operating, Inc.

424B3

333-258681

Annex A

November 10, 2021

2.2

First Amendment to the Business Combination Agreement, dated October 12, 2021, by and among the Company, DCRC Merger Sub, Inc., and Solid Power Operating, Inc.

424B3

333-258681

Annex A-1

November 10, 2021

3.1

Second Amended and Restated Certificate of Incorporation

8-K

001-40284

3.1

December 13, 2021

3.2

Amended and Restated Bylaws

8-K

001-40284

3.1

November 21, 2022

10.1±

Second Amendment to Joint Development Agreement, dated June 30, 2023, between Solid Power Operating, Inc. and Ford Motor Company

8-K

001-40284

10.1

July 5, 2023

10.2#

Offer Letter with John Van Scoter, dated May 26, 2023

8-K

001-40284

10.1

May 31, 2023

31.1*

Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

31.2*

Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

32.1**

Section 1350 Certification

32.2**

Section 1350 Certification

101.INS*

XBRL Instance Document – the instance document does not appear in the Interactive Data file because its Inline XBRL tags are embedded within the Inline XBRL document.

101.SCH*

Inline XBRL Taxonomy Extension Schema Document

101.CAL*

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF*

Inline XBRL Taxonomy Extension Definition Document

101.LAB*

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*

Inline XBRL Taxonomy Extension Presentation Linkbase

104*

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed herewith.

** Furnished herewith.

± Certain portions of this exhibit have been omitted in accordance with Regulation S-K Item 601. The Company agrees to furnish an unredacted copy of the exhibit to the SEC upon request.

# Indicates a management or compensatory plan.

23

SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 9, 2023

Solid Power, Inc.

By:

/s/ John Van Scoter

Name:

John Van Scoter

Title:

President, Chief Executive Officer, and Director

(Principal Executive Officer)

By:

/s/ Kevin Paprzycki

Name:

Kevin Paprzycki

Title:

Chief Financial Officer and Treasurer

(Principal Financial and Accounting Officer)

24

Exhibit 31.1

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE

SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION

302 OF THE SARBANES-OXLEY ACT OF 2002

I, John Van Scoter, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Solid Power, Inc. for the quarterly period ended June 30, 2023;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: August 9, 2023

By:

/s/ John Van Scoter

John Van Scoter

President and Chief Executive Officer

(Principal Executive Officer)


Exhibit 31.2

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE

SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION

302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kevin Paprzycki, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Solid Power, Inc. for the quarterly period ended June 30, 2023;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: August 9, 2023

By:

/s/ Kevin Paprzycki

Kevin Paprzycki

Chief Financial Officer and Treasurer

(Principal Financial and Accounting Officer)


Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Solid Power, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, to the best of my knowledge, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 9, 2023

By:

/s/ John Van Scoter

John Van Scoter

President and Chief Executive Officer

(Principal Executive Officer)


Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Solid Power, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, to the best of my knowledge, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 9, 2023

By:

/s/ Kevin Paprzycki

Kevin Paprzycki

Chief Financial Officer and Treasurer

(Principal Financial and Accounting Officer)


v3.23.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2023
Aug. 07, 2023
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Entity File Number 001-40284  
Entity Registrant Name SOLID POWER, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 86-1888095  
Entity Address, Address Line One 486 S. Pierce Ave., Suite E  
Entity Address, City or Town Louisville  
Entity Address State Or Province CO  
Entity Address, Postal Zip Code 80027  
City Area Code 303  
Local Phone Number 219-0720  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   178,390,443
Entity Central Index Key 0001844862  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Common Stock [Member]    
Title of 12(b) Security Common stock, par value $0.0001 per share  
Trading Symbol SLDP  
Security Exchange Name NASDAQ  
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50    
Title of 12(b) Security Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50  
Trading Symbol SLDPW  
Security Exchange Name NASDAQ  
v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 28,439 $ 50,123
Marketable securities 192,694 272,957
Contract receivables 5,224 1,840
Prepaid expenses and other current assets 3,494 2,888
Total current assets 229,851 327,808
Property, Plant and Equipment, net 95,076 82,761
Right-Of-Use Operating Lease Asset, net 7,444 7,725
Right-Of-Use Financing Lease Asset, net 938 922
Other Assets 1,087 1,148
Long-term Investments 222,255 172,974
Intangible Assets, net 1,360 1,108
Total assets 558,011 594,446
Current Liabilities    
Accounts payable and other accrued liabilities 8,065 11,326
Current portion of long-term debt   7
Deferred revenue 18 4,050
Accrued compensation 4,080 4,528
Operating lease liabilities, short-term 586 549
Financing lease liability, short-term 308 273
Total current liabilities 13,057 20,733
Warrant Liabilities 6,791 9,117
Operating Lease Liabilities, Long-Term 8,317 8,622
Financing Lease Liabilities, Long-Term 535 602
Total liabilities 28,700 39,074
Stockholders' Equity    
Common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 178,326,890 and 176,007,184 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 18 18
Additional paid-in capital 583,034 577,603
Accumulated deficit (50,369) (19,090)
Accumulated other comprehensive loss (3,372) (3,159)
Total stockholders' equity 529,311 555,372
Total liabilities and stockholders' equity $ 558,011 $ 594,446
v3.23.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Condensed Consolidated Balance Sheets    
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 2,000,000,000 2,000,000,000
Common stock, shares issued 178,326,890 176,007,184
Common stock, shares outstanding 178,326,890 176,007,184
v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)        
Revenue $ 4,906 $ 2,582 $ 8,698 $ 4,778
Operating Expenses        
Direct costs 6,897 2,987 13,171 5,017
Research and development 14,508 8,440 26,156 15,101
Selling, general and administrative 5,673 5,851 12,862 10,670
Total operating expenses 27,078 17,278 52,189 30,788
Operating Loss (22,172) (14,696) (43,491) (26,010)
Nonoperating Income and Expense        
Interest income 4,993 931 9,827 1,171
Change in fair value of warrant liabilities 4,987 27,473 2,325 28,183
Interest expense (13) (5) (26) (10)
Total nonoperating income and expense 9,967 28,399 12,126 29,344
Pretax Income (Loss) (12,205) 13,703 (31,365) 3,334
Income tax benefit   36   13
Net Income (Loss) Attributable to Common Stockholders (12,205) 13,667 (31,365) 3,321
Other Comprehensive Income (Loss) 1,098 (961) (213) (1,291)
Comprehensive Income (Loss) Attributable to Common Stockholders $ (11,107) $ 12,706 $ (31,578) $ 2,030
Earnings (loss) per share - Basic $ (0.07) $ 0.08 $ (0.18) $ 0.02
Earnings (loss) per share - Diluted $ (0.07) $ 0.08 $ (0.18) $ 0.02
Weighted average shares outstanding - Basic 178,063,573 174,128,230 177,502,037 173,266,760
Weighted average shares outstanding - Diluted 178,063,573 174,703,533 177,502,037 173,566,001
v3.23.2
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated OCI
Total
Balance at the beginning at Dec. 31, 2021 $ 17 $ 568,183 $ (9,535)   $ 558,665
Balance at the beginning (in shares) at Dec. 31, 2021 167,557,988        
Changes in stockholder's equity          
Net loss     (10,344)   (10,344)
Transaction fees   (12)     (12)
Stock options exercised   270     270
Stock options exercised (in shares) 6,212,964        
Stock-based compensation expense   1,596     1,596
Unrealized loss on marketable securities       $ (330) (330)
Balance at the end at Mar. 31, 2022 $ 17 570,037 (19,879) (330) 549,845
Balance at the end (in shares) at Mar. 31, 2022 173,770,952        
Balance at the beginning at Dec. 31, 2021 $ 17 568,183 (9,535)   558,665
Balance at the beginning (in shares) at Dec. 31, 2021 167,557,988        
Changes in stockholder's equity          
Net loss         3,321
Shares issued for the vesting of RSUs (in shares) 20,672        
Stock options exercised (in shares) 6,869,144        
Balance at the end at Jun. 30, 2022 $ 17 572,456 (6,212) (1,291) 564,970
Balance at the end (in shares) at Jun. 30, 2022 174,447,804        
Balance at the beginning at Mar. 31, 2022 $ 17 570,037 (19,879) (330) 549,845
Balance at the beginning (in shares) at Mar. 31, 2022 173,770,952        
Changes in stockholder's equity          
Net loss     13,667   13,667
Withholding of employee taxes related to stock-based compensation   (58)     (58)
Shares issued for the vesting of RSUs (in shares) 20,672        
Stock options exercised   163     163
Stock options exercised (in shares) 656,180        
Stock-based compensation expense   2,314     2,314
Unrealized loss on marketable securities       (961) (961)
Balance at the end at Jun. 30, 2022 $ 17 572,456 (6,212) (1,291) 564,970
Balance at the end (in shares) at Jun. 30, 2022 174,447,804        
Balance at the beginning at Dec. 31, 2022 $ 18 577,603 (19,090) (3,159) 555,372
Balance at the beginning (in shares) at Dec. 31, 2022 176,007,184        
Changes in stockholder's equity          
Net loss     (19,158)   (19,158)
Stock options exercised   150     150
Stock options exercised (in shares) 1,679,954        
Stock-based compensation expense   2,222     2,222
Unrealized loss on marketable securities       885 885
Balance at the end at Mar. 31, 2023 $ 18 579,975 (38,248) (2,274) 539,471
Balance at the end (in shares) at Mar. 31, 2023 177,687,138        
Balance at the beginning at Dec. 31, 2022 $ 18 577,603 (19,090) (3,159) 555,372
Balance at the beginning (in shares) at Dec. 31, 2022 176,007,184        
Changes in stockholder's equity          
Net loss         (31,365)
Shares issued under ESPP (in shares) 129,928        
Shares issued for the vesting of RSUs (in shares) 163,148        
Stock options exercised (in shares) 2,026,630        
Balance at the end at Jun. 30, 2023 $ 18 583,034 (50,369) (3,372) 529,311
Balance at the end (in shares) at Jun. 30, 2023 178,326,890        
Balance at the beginning at Mar. 31, 2023 $ 18 579,975 (38,248) (2,274) 539,471
Balance at the beginning (in shares) at Mar. 31, 2023 177,687,138        
Changes in stockholder's equity          
Net loss     (12,205)   (12,205)
Shares issued under ESPP   214     214
Shares issued under ESPP (in shares) 129,928        
Withholding of employee taxes related to stock-based compensation   (111) 84   (27)
Shares issued for the vesting of RSUs (in shares) 163,148        
Stock options exercised   33     33
Stock options exercised (in shares) 346,676        
Stock-based compensation expense   2,923     2,923
Unrealized loss on marketable securities       (1,098) (1,098)
Balance at the end at Jun. 30, 2023 $ 18 $ 583,034 $ (50,369) $ (3,372) $ 529,311
Balance at the end (in shares) at Jun. 30, 2023 178,326,890        
v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities    
Net income (loss) $ (31,365) $ 3,321
Adjustments to reconcile net income (loss) to net cash and cash equivalents from operating activities:    
Depreciation and amortization 4,906 1,782
Amortization of right-of-use assets 372 16
Stock compensation expense 5,145 3,910
Deferred taxes   13
Change in fair value of warrant liabilities (2,325) (28,183)
Amortization of premiums and accretion of discounts on marketable securities (5,518)  
Change in operating assets and liabilities that provided (used) cash and cash equivalents:    
Contract receivable (3,383) (1,202)
Prepaid expenses and other assets (188) 744
Accounts payable and other accrued liabilities (297) (4,261)
Deferred revenue (4,032) (286)
Accrued expenses 649 1,000
Lease liabilities (268) 188
Net cash and cash equivalents used in operating activities (36,304) (22,958)
Cash Flows from Investing Activities    
Purchases of property, plant and equipment (21,184) (30,957)
Purchases of marketable securities and long-term investments (174,400) (212,792)
Proceeds from sales of marketable securities 210,329 54,819
Purchases of intangible assets (259) (228)
Net cash and cash equivalents provided by (used in) investing activities 14,486 (189,158)
Cash Flows from Financing Activities    
Payments of debt (7) (71)
Proceeds from exercise of stock options 184 354
Proceeds from issuance of common stock under ESPP 214 0
Receivable for exercise of stock options   79
Cash paid for withholding of employee taxes related to stock-based compensation (111) (58)
Payments on finance lease liability (146) (20)
Transaction costs   (12)
Net cash and cash equivalents provided by financing activities 134 272
Net (decrease) in cash and cash equivalents (21,684) (211,844)
Cash and cash equivalents at beginning of period 50,123 513,447
Cash and cash equivalents at end of period 28,439 301,603
Supplemental information    
Cash paid for interest 26 5
Accrued capital expenditures $ 3,591 $ 8,146
v3.23.2
Nature of Business
6 Months Ended
Jun. 30, 2023
Nature of Business  
Nature of Business

Note 1 – Nature of Business

Solid Power, Inc. (the “Company”) is developing solid state battery technology to enable the next generation of batteries for the fast-growing EV and other markets. The Company’s planned business model is to sell its sulfide-based solid electrolyte and to license its solid-state cell designs and manufacturing process.

v3.23.2
Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Significant Accounting Policies  
Significant Accounting Policies

Note 2 – Significant Accounting Policies

The significant accounting policies followed by the Company are set forth in Note 2 – Significant Accounting Policies to the Company’s financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”) and are supplemented by the Notes to the Condensed Consolidated Financial Statements (Unaudited) (the “Notes”) included in this Quarterly Report on Form 10-Q for the period ended June 30, 2023 (this “Report”). The financial statements included in this Report (including the Notes) should be read in conjunction with the 2022 Form 10-K.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared on the basis of generally accepted accounting principles in the United States (“GAAP”). The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from those estimates. All dollar amounts presented herein are in U.S. dollars and are in thousands, except par value, share and per share amounts.

The accompanying unaudited condensed consolidated financial statements include accounts of the Company and its wholly owned subsidiary, Solid Power Operating, Inc. All intercompany balances and transactions have been eliminated in consolidation. Additionally, certain prior period amounts have been reclassified to conform to current period presentation in the accompanying unaudited condensed consolidated financial statements.

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), followed by other related ASUs that provided targeted improvements and additional practical expedient options. On January 1, 2022, the Company adopted the standards under Topic 842 using the modified retrospective method and elected a number of the practical expedients in its implementation of Topic 842. The key change that affected the Company relates to accounting for operating leases for which it is the lessee that were historically off-balance sheet.

Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. ASU 2016-13 also provides updated guidance regarding the impairment of available-for-sale debt securities and includes additional disclosure requirements. The Company adopted this guidance as of January 1, 2022.

The Company regularly reviews its available-for-sale marketable securities and evaluates the current expected credit losses by considering factors such as any changes in credit ratings, historical experience, market data, issuer-specific factors, and current economic conditions. Based on this analysis, any allowance for credit losses is immaterial and would be recorded as a reduction to the carrying value of the asset.

The Company reviews its receivable aging on an individual customer level, considering collectability of cash flows based on the risk of past events, current conditions, and forward-looking information. The Company establishes allowances for bad debts equal to the estimable portions of accounts receivable for which failure to collect is expected to occur. Allowances for doubtful accounts are recorded as reductions to the carrying values of the related receivables. To date, the Company has not recorded an allowance for doubtful accounts.

v3.23.2
Property, Plant and Equipment
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment  
Property, Plant and Equipment

Note 3 – Property, Plant and Equipment

Property, plant and equipment are summarized as follows:

    

June 30, 2023

    

December 31, 2022

Commercial production equipment

$

25,454

$

21,595

Laboratory equipment

7,554

3,278

Leasehold improvements

 

45,581

 

27,996

Furniture and computer equipment

 

1,634

 

1,482

Construction in progress

 

31,317

 

40,036

Total cost

 

111,540

 

94,387

Accumulated depreciation

 

(16,464)

 

(11,626)

Net property and equipment

$

95,076

$

82,761

Depreciation expenses for dedicated laboratory equipment and commercial production equipment are charged to research and development. The other depreciation expenses are included in the Company’s overhead and are allocated across operating expenses on the accompanying Condensed Consolidated Statements of Operations based on Company personnel costs incurred.

Depreciation expense related to property, plant, and equipment are summarized as follows:

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

    

2022

2023

    

2022

Depreciation expense

$

2,639

$

1,026

$

4,898

$

1,777

In 2022, the Company expanded its cell production capabilities through the construction of a second dry room and installation of a second cell pilot production line at its Louisville, Colorado facility, which is designed to produce larger format solid-state battery cells for the automotive qualification process.

The Company expanded its electrolyte production at its facility in Thornton, Colorado. Scaling this production will allow it to produce larger quantities of electrolyte material required to feed cell-production lines and continue research and development efforts. The Company began producing electrolyte at this facility in 2023 and has placed portions of the facility into service.

June 30, 2023

December 31, 2022

Construction in progress

EV cell line (SP1)

$

1,083

$

2,010

Other cell development equipment (SP1)

2,703

2,206

Electrolyte production and development equipment (SP2)

27,531

35,820

v3.23.2
Intangible Assets
6 Months Ended
Jun. 30, 2023
Intangible Assets  
Intangible Assets

Note 4 – Intangible Assets

Intangible assets of the Company are summarized as follows:

    

June 30, 2023

    

December 31, 2022

Gross Carrying

Accumulated

Gross Carrying

Accumulated

    

Amount

    

Amortization

    

Amount

    

Amortization

Intangible assets:

Licenses

$

149

$

(56)

$

149

$

(51)

Patents

72

(3)

Patents pending

 

1,168

 

 

984

 

Trademarks

13

9

Trademarks pending

 

17

 

 

17

 

Total amortized intangible assets

$

1,419

$

(59)

$

1,159

$

(51)

Amortization expense for intangible assets is summarized as follows:

Three Months Ended June 30, 

Six Months Ended June 30, 

 

    

2023

    

2022

2023

    

2022

 

Amortization expense

$

3

$

2

$

8

$

5

Useful lives of intangible assets range from three to 20 years. Amortization expenses are allocated ratably across operating expenses on the accompanying condensed consolidated statements of operations.

v3.23.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2023
Fair Value Measurements  
Fair Value Measurements

Note 5 – Fair Value Measurements

The carrying amounts of certain financial instruments, such as cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued liabilities, approximate fair value due to their relatively short maturities.

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

As of June 30, 2023 and December 31, 2022, the Company’s financial assets and liabilities measured and recorded at fair value on a recurring basis were classified within the fair value hierarchy as follows:

June 30, 2023

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

Commercial Paper

$

137,072

$

$

$

137,072

Corporate Bonds

$

216,390

$

$

$

216,390

Government Bonds

$

61,487

$

$

$

61,487

U.S. Treasuries

 

 

Liabilities

Public Warrants

$

3,932

$

$

$

3,932

Private Placement Warrants

$

$

2,859

$

$

2,859

December 31, 2022

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

Commercial Paper

$

165,179

$

$

$

165,179

Corporate Bonds

$

227,957

$

$

$

227,957

Government Bonds

$

42,865

$

$

$

42,865

U.S. Treasuries

 

9,930

 

9,930

Liabilities

Public Warrants

$

4,900

$

$

$

4,900

Private Placement Warrants

$

$

4,217

$

$

4,217

The change in fair value of the Company’s marketable securities and long-term investments are included in other comprehensive loss. There were no transfers in and out of Level 3 fair value hierarchy during the three or six months ended June 30, 2023 or year ended December 31, 2022. For the three and six months ended June 30, 2023, the Company purchased $174,400 of marketable securities.

Fair Value of Warrants

The fair value of the Private Placement Warrants (defined below) has been estimated using a Black-Scholes model as of June 30, 2023 and December 31, 2022 Consolidated Balance Sheet dates. The fair value of the Public Warrants (defined below) has been measured based on the quoted price of such warrants on the Nasdaq Stock Market, a Level 1 input. The estimated fair value of the Private Placement Warrants is determined using Level 2 inputs. Inherent in a Black-Scholes model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. Material increases (or decreases) in any of those inputs may result in a significantly higher (or lower) fair value measurement. The Company estimates the volatility of its Private Placement Warrants based on implied volatility from the Company’s Public Warrants and from historical volatility of select peer

companies’ common stock that matches the expected remaining life of the Warrants (defined below). The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve for a maturity similar to the expected remaining life of the Warrants. The expected life of the Warrants is assumed to be equivalent to their remaining contractual term. The dividend yield is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 2 inputs used in the recurring valuation of the Private Placement Warrants as of their measurement dates:

    

June 30, 2023

    

December 31, 2022

 

Exercise Price

$

11.50

$

11.50

Stock Price

$

2.54

$

2.54

Volatility

 

70.0

%  

 

71.3

%

Term

 

3.44

 

3.94

Risk-free rate

 

4.32

%  

 

4.03

%

The following table provides a reconciliation of the Public Warrants measured at fair value using Level 1 directly observable inputs and Private Placement Warrants measured at fair value using Level 2 directly or indirectly observable inputs:

Public Warrants

Private Placement Warrants

    

Level 1 Fair Value

    

Level 2 Fair Value

December 31, 2022

$

0.42

$

0.55

Change in fair value

$

0.04

$

0.31

March 31, 2023

$

0.46

$

0.86

Change in fair value

$

(0.15)

$

(0.43)

June 30, 2023

$

0.31

$

0.43

The following tables provides a reconciliation of the June 30, 2023 three and six month change in fair value for the Public Warrants and Private Placement Warrants:

Three months change in

Warrant Class

    

Level

    

Warrants

    

March 31, 2023

    

fair value

    

June 30, 2023

Public Warrants

 

1

 

12,684,423

$

5,576

$

(1,644)

$

3,932

Private Placement Warrants

 

2

 

6,648,880

$

6,203

$

(3,343)

$

2,860

Total

 

  

 

19,333,303

$

11,779

$

(4,987)

$

6,792

Six months change in

Warrant Class

    

Level

    

Warrants

    

December 31, 2022

    

fair value

    

June 30, 2023

Public Warrants

 

1

 

12,684,423

$

4,900

$

(968)

$

3,932

Private Placement Warrants

 

2

 

6,648,880

$

4,217

$

(1,357)

$

2,860

Total

 

  

 

19,333,303

$

9,117

$

(2,325)

$

6,792

v3.23.2
Warrant Liabilities
6 Months Ended
Jun. 30, 2023
Warrant Liabilities.  
Warrant Liabilities

Note 6 – Warrant Liabilities

As of June 30, 2023 and December 31, 2022, there were 12,684,423 and 11,666,636 publicly traded warrants (“Public Warrants”) and 6,648,880 and 7,666,667 private placement warrants (“Private Placement Warrants,” and together with the Public Warrants, “Warrants”) outstanding, respectively. Each whole Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to customary adjustments. Only whole Warrants are exercisable. The Warrants became exercisable on January 7, 2022 and will expire on December 8, 2026.

None of the Private Placement Warrants are redeemable by the Company so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees.

The Warrants were initially measured at fair value upon closing of the transactions contemplated by the Business Combination Agreement and Plan of Reorganization, dated June 15, 2021 by and among the Company, DCRC Merger Sub, Inc., and Solid Power Operating, Inc., as amended, for $101,253 and subsequently re-measured at each reporting period. The Public Warrants were allocated a portion of the proceeds from the issuance of the units of common stock and one-third warrants in Decarbonization Plus Acquisition Corporation III’s initial public offering equal to their fair value. The Company recognized a gain in connection with

changes in the fair value of warrant liabilities of $4,987 and $2,325 for the three and six months ending June 30, 2023 and $27,473 and $28,183 for the three and six months ending June 30, 2022, respectively.

There have been no changes to our Public or Private Placement Warrants, including redemption terms disclosed in our 2022 Form 10-K.

v3.23.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2023
Stockholders' Equity  
Stockholders' Equity

Note 7 – Stockholders’ Equity

Common Stock

Stock options exercised for Common Stock, shares issued under the Solid Power, Inc. 2021 Employee Stock Purchase Plan (“ESPP”), and shares issued upon vesting of RSUs for the three and six months ended June 30, 2023 and 2022 are summarized in the table below:

Three months ended June 30, 

Six months ended June 30, 

    

2023

    

2022

2023

    

2022

Stock options exercised

346,676

656,180

2,026,630

6,869,144

Shares issued under ESPP

129,928

129,928

Shares issued upon vesting of RSUs

163,148

20,672

163,148

20,672

Cash received from stock options exercised under the Solid Power, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) for the six months ended June 30, 2023 and 2022 was $184 and $354, respectively. Cash received from stock options exercised under the 2014 Plan for the three months ended June 30, 2023 and 2022 was $34 and $84, respectively.

Cash received from shares issued under the ESPP for the six months ended June 30, 2023 and 2022 was $214 and $0, respectively. Cash received from shares issued under the ESPP for the three months ended June 30, 2023 and 2022 was $214 and $0, respectively.

v3.23.2
Stock Based Compensation
6 Months Ended
Jun. 30, 2023
Stock Based Compensation  
Stock Based Compensation

Note 8 – Stock Based Compensation

There have been no changes to our equity incentive plans, Employee Stock Purchase Plan, or accounting methodology for stock based compensation, as disclosed in our 2022 Form 10-K.

The fair value of stock options and Restricted Stock Units (“RSUs”) issued to employees and directors is recognized as compensation expense over the period of service that generally coincides with the vesting period of the award. The Company allocated compensation ratably across Operating Expenses. When calculating the amount of annual compensation expense, the Company has elected not to estimate forfeitures and instead accounts for forfeitures as they occur.

For the three and six months ended June 30, 2023, the Company recognized compensation costs totaling:

Three months ended June 30, 

Six months ended June 30, 

    

2023

    

2022

2023

    

2022

Equity-based compensation costs related to RSUs

$

954

$

514

$

1,589

$

514

Equity-based compensation costs related to stock options

 

1,889

 

1,800

 

3,476

 

3,396

Equity-based compensation costs related to ESPP

80

80

Total equity-based compensation costs

$

2,923

$

2,314

$

5,145

$

3,910

Unrecognized future compensation cost as of

34,327

25,316

The following table summarizes our award activity for RSUs and stock options for the three and six months ended June 30, 2023:

    

RSUs

Stock Options

Balance at December 31, 2022

1,057,980

 

25,998,172

Granted

1,797,034

3,272,873

Vested or Exercised

(1,679,954)

Forfeited

(88,441)

(1,494,020)

Balance at March 31, 2023

2,766,573

26,097,071

Granted

1,753,207

1,904,016

Vested or Exercised

(215,553)

(346,676)

Forfeited

(47,181)

(466,635)

Outstanding at June 30, 2023

4,257,046

27,187,776

Stock Options

The fair value of each stock option grant during the six months ended June 30, 2023 and 2022 was estimated on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions used:

    

Six months ended June 30, 

 

    

2023

 

2022

 

Approximate riskfree rate

 

4.17

%

2.84

%

Volatility

 

46.91

%

44.69

%

Average expected life (years)

 

6 years

6 years

Dividend yield

 

%

%

Weightedaverage grant date fair value

$

2.80

$

7.26

Estimated fair value of total stock options granted

$

7,815

$

5,659

v3.23.2
Earnings (Loss) Per Share
6 Months Ended
Jun. 30, 2023
Earnings (Loss) Per Share  
Earnings (Loss) Per Share

Note 9 – Earnings (Loss) Per Share

Basic earnings (loss) per share represents net income (loss) attributable to common stock divided by the basic weighted average number of common stock outstanding during the period.

Due to the net loss for the three and six months ended June 30, 2023, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. Due to the net income for the three and six months ended June 30, 2022, diluted earnings per share was computed with consideration to potentially dilutive instruments. Warrants outstanding in 2023 and 2022 were not included in the computation of diluted earnings per share because the Warrant’s exercise price for the period was greater than the average market price of the common stock.

The table below sets forth the basic and diluted earnings (loss) per share calculation for the three and six months ended June 30, 2023 and 2022.

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

2022

2023

2022

Net income (loss) attributable to common stockholders

$

(12,205)

$

13,667

$

(31,365)

$

3,321

Weighted average shares outstanding – basic

178,063,573

174,128,230

177,502,037

173,266,760

Weighted average shares outstanding – diluted

178,063,573

174,703,533

177,502,037

173,566,001

Basic and diluted earnings (loss) per share

$

(0.07)

$

0.08

$

(0.18)

$

0.02

As of the three and six months ended June 30, 2023, potentially dilutive securities excluded from the diluted loss per share calculation are as illustrated in the table below. Additionally, for the three and six months ended June 30, 2022, potentially dilutive securities included from the diluted earnings per share calculation are as follows (in shares):

Six Months Ended June 30, 

2023

    

2022

Warrants

19,333,303

 

19,333,303

2014 & 2021 Equity Incentive Plan - Stock Options

25,892,666

 

27,161,312

2021 Equity Incentive Plan - RSUs

2,474,393

 

1,674,284

2021 Employee Stock Purchase Plan - Common Stock

46,352

Contingently Issuable Common Stock

59,055

Total potentially dilutive securities

47,805,769

48,168,899

v3.23.2
Leases
6 Months Ended
Jun. 30, 2023
Leases  
Leases

Note 10 – Leases

The Company leases its two facilities and certain equipment. Fixed rent generally escalates each year, and the Company is responsible for a portion of the landlords’ operating expenses such as property tax, insurance, and common area maintenance.

The Company’s facility in Louisville, Colorado, is under a noncancelable operating lease with a maturity date in September 2029. In 2022, the Company amended the lease to incorporate a prior subleased space into the base lease and extend the term of the lease. The Company has the right to renew this lease for an additional five-year period.

On September 1, 2021, the Company entered into an industrial operating lease agreement for its facility in Thornton, Colorado, with the initial term through March 31, 2029. Under this operating lease, the Company has one option to renew for five years, which has been included in the calculation of lease liabilities and right-of-use assets at the adoption date of the lease accounting standard on January 1, 2022, as the exercise of the option was reasonably certain. As the renewal rent has not been negotiated, the Company used an estimated rent rate which approximated the fair market rent at adoption of ASC 842 on January 1, 2022 for the extension period.

The Company has certain equipment leases classified as finance leases as of June 30, 2023.

The Company’s leases do not have any contingent rent payments and do not contain residual value guarantees.

The components of lease expense are as follows:

    

Three Months Ended

    

Six Months Ended

    

June 30, 2023

    

June 30, 2023

Finance lease costs:

 

  

 

  

Amortization of right-of-use assets

$

47

$

91

Interest on lease liabilities

 

13

 

25

Operating lease costs

 

290

 

580

Total lease expense

$

350

$

696

The components of cash flow information related to leases are as follows:

    

Three Months Ended

    

Six Months Ended

    

June 30, 2023

    

June 30, 2023

Operating outgoing cash flows – finance lease

$

14

$

26

Financing outgoing cash flows – finance lease

 

74

 

141

Operating outgoing cash flows – operating lease

 

283

 

567

Right-of-use assets obtained in exchange for new finance lease liabilities:

79

89

Right-of-use assets obtained in exchange for new operating lease liabilities:

    

June 30, 2023

 

Finance lease

 

  

Weighted-average remaining lease term – finance lease (in years)

 

2.98

Weighted-average discount rate – finance lease

 

6.2

%

Operating lease

 

  

Weighted-average remaining lease term – operating lease (in years)

 

9.71

Weighted-average discount rate – operating lease

 

6.9

%

As of June 30, 2023, future minimum payments during the next five years and thereafter are as follows:

Fiscal year

    

Finance Lease

    

Operating Lease

2023 (remaining six months)

$

174

$

571

2024

349

1,173

2025

234

1,210

2026

109

1,248

2027

37

1,288

2028

16

1,329

Thereafter

5,244

Total

919

12,063

Less present value discount

77

3,158

Total lease liabilities

$

842

$

8,905

v3.23.2
Related Party Transactions
6 Months Ended
Jun. 30, 2023
Related Party Transactions  
Related Party Transactions

Note 11 – Related Party Transactions

During the three and six months ended June 30, 2023, the Company recognized $3,470 and $6,470, respectively, of revenue related to the BMW joint development agreement. As of June 30, 2023 the Company recorded $2,477 of accounts receivable related to the BMW joint development agreement.

v3.23.2
Income Taxes
6 Months Ended
Jun. 30, 2023
Income Taxes  
Income Taxes

Note 12 – Income Taxes

The Company’s effective tax rate was 0.00% and 0.27% for the three months ended June 30, 2023 and 2022, respectively, and 0.00% and 0.49% for the six months ended June 30, 2023 and 2022, respectively. The change in the effective tax rate between periods was due to the Company was being in a full valuation allowance for the three and six months ended June 30, 2023.

v3.23.2
Contingencies
6 Months Ended
Jun. 30, 2023
Contingencies  
Contingencies

Note 13 – Contingencies

In the normal course of business, the Company may be party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company.

v3.23.2
Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2023
Significant Accounting Policies  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared on the basis of generally accepted accounting principles in the United States (“GAAP”). The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from those estimates. All dollar amounts presented herein are in U.S. dollars and are in thousands, except par value, share and per share amounts.

The accompanying unaudited condensed consolidated financial statements include accounts of the Company and its wholly owned subsidiary, Solid Power Operating, Inc. All intercompany balances and transactions have been eliminated in consolidation. Additionally, certain prior period amounts have been reclassified to conform to current period presentation in the accompanying unaudited condensed consolidated financial statements.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), followed by other related ASUs that provided targeted improvements and additional practical expedient options. On January 1, 2022, the Company adopted the standards under Topic 842 using the modified retrospective method and elected a number of the practical expedients in its implementation of Topic 842. The key change that affected the Company relates to accounting for operating leases for which it is the lessee that were historically off-balance sheet.

Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. ASU 2016-13 also provides updated guidance regarding the impairment of available-for-sale debt securities and includes additional disclosure requirements. The Company adopted this guidance as of January 1, 2022.

The Company regularly reviews its available-for-sale marketable securities and evaluates the current expected credit losses by considering factors such as any changes in credit ratings, historical experience, market data, issuer-specific factors, and current economic conditions. Based on this analysis, any allowance for credit losses is immaterial and would be recorded as a reduction to the carrying value of the asset.

The Company reviews its receivable aging on an individual customer level, considering collectability of cash flows based on the risk of past events, current conditions, and forward-looking information. The Company establishes allowances for bad debts equal to the estimable portions of accounts receivable for which failure to collect is expected to occur. Allowances for doubtful accounts are recorded as reductions to the carrying values of the related receivables. To date, the Company has not recorded an allowance for doubtful accounts.

v3.23.2
Property, Plant and Equipment (Tables)
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment  
Schedule of property and equipment

    

June 30, 2023

    

December 31, 2022

Commercial production equipment

$

25,454

$

21,595

Laboratory equipment

7,554

3,278

Leasehold improvements

 

45,581

 

27,996

Furniture and computer equipment

 

1,634

 

1,482

Construction in progress

 

31,317

 

40,036

Total cost

 

111,540

 

94,387

Accumulated depreciation

 

(16,464)

 

(11,626)

Net property and equipment

$

95,076

$

82,761

Schedule of depreciation and amortization expense

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

    

2022

2023

    

2022

Depreciation expense

$

2,639

$

1,026

$

4,898

$

1,777

Schedule of construction in progress

June 30, 2023

December 31, 2022

Construction in progress

EV cell line (SP1)

$

1,083

$

2,010

Other cell development equipment (SP1)

2,703

2,206

Electrolyte production and development equipment (SP2)

27,531

35,820

v3.23.2
Intangible Assets (Tables)
6 Months Ended
Jun. 30, 2023
Intangible Assets  
Schedule of intangible assets

    

June 30, 2023

    

December 31, 2022

Gross Carrying

Accumulated

Gross Carrying

Accumulated

    

Amount

    

Amortization

    

Amount

    

Amortization

Intangible assets:

Licenses

$

149

$

(56)

$

149

$

(51)

Patents

72

(3)

Patents pending

 

1,168

 

 

984

 

Trademarks

13

9

Trademarks pending

 

17

 

 

17

 

Total amortized intangible assets

$

1,419

$

(59)

$

1,159

$

(51)

Schedule of amortization expense for intangible assets

Three Months Ended June 30, 

Six Months Ended June 30, 

 

    

2023

    

2022

2023

    

2022

 

Amortization expense

$

3

$

2

$

8

$

5

v3.23.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Measurements  
Schedule of financial assets and liabilities measured and recorded at fair value on a recurring basis

June 30, 2023

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

Commercial Paper

$

137,072

$

$

$

137,072

Corporate Bonds

$

216,390

$

$

$

216,390

Government Bonds

$

61,487

$

$

$

61,487

U.S. Treasuries

 

 

Liabilities

Public Warrants

$

3,932

$

$

$

3,932

Private Placement Warrants

$

$

2,859

$

$

2,859

December 31, 2022

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

Commercial Paper

$

165,179

$

$

$

165,179

Corporate Bonds

$

227,957

$

$

$

227,957

Government Bonds

$

42,865

$

$

$

42,865

U.S. Treasuries

 

9,930

 

9,930

Liabilities

Public Warrants

$

4,900

$

$

$

4,900

Private Placement Warrants

$

$

4,217

$

$

4,217

Schedule of Level 2 inputs used in the recurring valuation of the Private Placement Warrants

    

June 30, 2023

    

December 31, 2022

 

Exercise Price

$

11.50

$

11.50

Stock Price

$

2.54

$

2.54

Volatility

 

70.0

%  

 

71.3

%

Term

 

3.44

 

3.94

Risk-free rate

 

4.32

%  

 

4.03

%

Schedule of reconciliation of warrants measured at fair value

Public Warrants

Private Placement Warrants

    

Level 1 Fair Value

    

Level 2 Fair Value

December 31, 2022

$

0.42

$

0.55

Change in fair value

$

0.04

$

0.31

March 31, 2023

$

0.46

$

0.86

Change in fair value

$

(0.15)

$

(0.43)

June 30, 2023

$

0.31

$

0.43

Schedule of change in fair value for the Public Warrants and Private Placement Warrants

Three months change in

Warrant Class

    

Level

    

Warrants

    

March 31, 2023

    

fair value

    

June 30, 2023

Public Warrants

 

1

 

12,684,423

$

5,576

$

(1,644)

$

3,932

Private Placement Warrants

 

2

 

6,648,880

$

6,203

$

(3,343)

$

2,860

Total

 

  

 

19,333,303

$

11,779

$

(4,987)

$

6,792

Six months change in

Warrant Class

    

Level

    

Warrants

    

December 31, 2022

    

fair value

    

June 30, 2023

Public Warrants

 

1

 

12,684,423

$

4,900

$

(968)

$

3,932

Private Placement Warrants

 

2

 

6,648,880

$

4,217

$

(1,357)

$

2,860

Total

 

  

 

19,333,303

$

9,117

$

(2,325)

$

6,792

v3.23.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Stockholders' Equity  
Schedule of stock options exercised

Three months ended June 30, 

Six months ended June 30, 

    

2023

    

2022

2023

    

2022

Stock options exercised

346,676

656,180

2,026,630

6,869,144

Shares issued under ESPP

129,928

129,928

Shares issued upon vesting of RSUs

163,148

20,672

163,148

20,672

v3.23.2
Stock Based Compensation (Tables)
6 Months Ended
Jun. 30, 2023
Stock Based Compensation  
Schedule of recognized & allocated compensation costs

Three months ended June 30, 

Six months ended June 30, 

    

2023

    

2022

2023

    

2022

Equity-based compensation costs related to RSUs

$

954

$

514

$

1,589

$

514

Equity-based compensation costs related to stock options

 

1,889

 

1,800

 

3,476

 

3,396

Equity-based compensation costs related to ESPP

80

80

Total equity-based compensation costs

$

2,923

$

2,314

$

5,145

$

3,910

Unrecognized future compensation cost as of

34,327

25,316

Schedule of award activity for stock options and RSU's

The following table summarizes our award activity for RSUs and stock options for the three and six months ended June 30, 2023:

    

RSUs

Stock Options

Balance at December 31, 2022

1,057,980

 

25,998,172

Granted

1,797,034

3,272,873

Vested or Exercised

(1,679,954)

Forfeited

(88,441)

(1,494,020)

Balance at March 31, 2023

2,766,573

26,097,071

Granted

1,753,207

1,904,016

Vested or Exercised

(215,553)

(346,676)

Forfeited

(47,181)

(466,635)

Outstanding at June 30, 2023

4,257,046

27,187,776

Schedule of fair value of each option using the Black-Scholes option pricing model

    

Six months ended June 30, 

 

    

2023

 

2022

 

Approximate riskfree rate

 

4.17

%

2.84

%

Volatility

 

46.91

%

44.69

%

Average expected life (years)

 

6 years

6 years

Dividend yield

 

%

%

Weightedaverage grant date fair value

$

2.80

$

7.26

Estimated fair value of total stock options granted

$

7,815

$

5,659

v3.23.2
Earnings (Loss) Per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings (Loss) Per Share  
Schedule of reconciliation of basic weighted average common shares outstanding to diluted weighted average shares outstanding

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

2022

2023

2022

Net income (loss) attributable to common stockholders

$

(12,205)

$

13,667

$

(31,365)

$

3,321

Weighted average shares outstanding – basic

178,063,573

174,128,230

177,502,037

173,266,760

Weighted average shares outstanding – diluted

178,063,573

174,703,533

177,502,037

173,566,001

Basic and diluted earnings (loss) per share

$

(0.07)

$

0.08

$

(0.18)

$

0.02

Schedule of potentially dilutive securities excluded from the diluted earnings per share calculation

Six Months Ended June 30, 

2023

    

2022

Warrants

19,333,303

 

19,333,303

2014 & 2021 Equity Incentive Plan - Stock Options

25,892,666

 

27,161,312

2021 Equity Incentive Plan - RSUs

2,474,393

 

1,674,284

2021 Employee Stock Purchase Plan - Common Stock

46,352

Contingently Issuable Common Stock

59,055

Total potentially dilutive securities

47,805,769

48,168,899

v3.23.2
Leases (Tables)
6 Months Ended
Jun. 30, 2023
Leases  
Schedule of components of lease related expense

    

Three Months Ended

    

Six Months Ended

    

June 30, 2023

    

June 30, 2023

Finance lease costs:

 

  

 

  

Amortization of right-of-use assets

$

47

$

91

Interest on lease liabilities

 

13

 

25

Operating lease costs

 

290

 

580

Total lease expense

$

350

$

696

Schedule of components of cash flow information related to leases

    

Three Months Ended

    

Six Months Ended

    

June 30, 2023

    

June 30, 2023

Operating outgoing cash flows – finance lease

$

14

$

26

Financing outgoing cash flows – finance lease

 

74

 

141

Operating outgoing cash flows – operating lease

 

283

 

567

Right-of-use assets obtained in exchange for new finance lease liabilities:

79

89

Right-of-use assets obtained in exchange for new operating lease liabilities:

Schedule of remaining weighted-average lease term and weighted-average discount rate

    

June 30, 2023

 

Finance lease

 

  

Weighted-average remaining lease term – finance lease (in years)

 

2.98

Weighted-average discount rate – finance lease

 

6.2

%

Operating lease

 

  

Weighted-average remaining lease term – operating lease (in years)

 

9.71

Weighted-average discount rate – operating lease

 

6.9

%

Schedule of future minimum payments under finance lease

As of June 30, 2023, future minimum payments during the next five years and thereafter are as follows:

Fiscal year

    

Finance Lease

    

Operating Lease

2023 (remaining six months)

$

174

$

571

2024

349

1,173

2025

234

1,210

2026

109

1,248

2027

37

1,288

2028

16

1,329

Thereafter

5,244

Total

919

12,063

Less present value discount

77

3,158

Total lease liabilities

$

842

$

8,905

Schedule of future minimum payments under operating lease

Fiscal year

    

Finance Lease

    

Operating Lease

2023 (remaining six months)

$

174

$

571

2024

349

1,173

2025

234

1,210

2026

109

1,248

2027

37

1,288

2028

16

1,329

Thereafter

5,244

Total

919

12,063

Less present value discount

77

3,158

Total lease liabilities

$

842

$

8,905

v3.23.2
Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment    
Gross property and equipment $ 111,540 $ 94,387
Accumulated depreciation (16,464) (11,626)
Net property and equipment 95,076 82,761
Commercial production equipment    
Property, Plant and Equipment    
Gross property and equipment 25,454 21,595
Laboratory equipment    
Property, Plant and Equipment    
Gross property and equipment 7,554 3,278
Leasehold improvements    
Property, Plant and Equipment    
Gross property and equipment 45,581 27,996
Furniture and computer equipment    
Property, Plant and Equipment    
Gross property and equipment 1,634 1,482
Construction in progress    
Property, Plant and Equipment    
Gross property and equipment $ 31,317 $ 40,036
v3.23.2
Property, Plant and Equipment - Depreciation expense (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Property and Equipment        
Depreciation expense     $ 4,906 $ 1,782
Property, Plant and Equipment        
Property and Equipment        
Depreciation expense $ 2,639 $ 1,026 $ 4,898 $ 1,777
v3.23.2
Property, Plant and Equipment - Construction in progress (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
EV cell line    
Property, Plant and Equipment    
Construction in progress $ 1,083 $ 2,010
Other cell development equipment    
Property, Plant and Equipment    
Construction in progress 2,703 2,206
Electrolyte production and development equipment    
Property, Plant and Equipment    
Construction in progress $ 27,531 $ 35,820
v3.23.2
Intangible Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Intangible assets:    
Gross Carrying Amount $ 1,419 $ 1,159
Accumulated Amortization $ (59) (51)
Minimum    
Intangible assets:    
Estimated useful life of intangible assets 3 years  
Maximum    
Intangible assets:    
Estimated useful life of intangible assets 20 years  
Licenses    
Intangible assets:    
Gross Carrying Amount $ 149 149
Accumulated Amortization (56) (51)
Patents    
Intangible assets:    
Gross Carrying Amount 72  
Accumulated Amortization (3)  
Patents pending    
Intangible assets:    
Gross Carrying Amount 1,168 984
Trademarks    
Intangible assets:    
Gross Carrying Amount 13 9
Trademarks pending    
Intangible assets:    
Gross Carrying Amount $ 17 $ 17
v3.23.2
Intangible Assets - Amortization expense (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Intangible Assets        
Amortization expense $ 3 $ 2 $ 8 $ 5
v3.23.2
Fair Value Measurements - Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Liabilities      
Purchase of marketable securities $ 174,400 $ 174,400  
Recurring | Public Warrants      
Liabilities      
Liabilities 3,932 3,932 $ 4,900
Recurring | Private Placement Warrants      
Liabilities      
Liabilities 2,859 2,859 4,217
Recurring | Level 1 | Public Warrants      
Liabilities      
Liabilities 3,932 3,932 4,900
Recurring | Level 2 | Private Placement Warrants      
Liabilities      
Liabilities 2,859 2,859 4,217
Recurring | Level 3      
Liabilities      
Transfers in or out of Level 3 0 0 0
Recurring | Commercial Paper      
Assets      
Assets 137,072 137,072 165,179
Recurring | Commercial Paper | Level 1      
Assets      
Assets 137,072 137,072 165,179
Recurring | Corporate Bonds      
Assets      
Assets 216,390 216,390 227,957
Recurring | Corporate Bonds | Level 1      
Assets      
Assets 216,390 216,390 227,957
Recurring | Municipal Bonds      
Assets      
Assets 61,487 61,487 42,865
Recurring | Municipal Bonds | Level 1      
Assets      
Assets $ 61,487 $ 61,487 42,865
Recurring | U.S. Treasuries      
Assets      
Assets     9,930
Recurring | U.S. Treasuries | Level 1      
Assets      
Assets     $ 9,930
v3.23.2
Fair Value Measurements - Measurement inputs (Details) - Recurring - Level 2 - Private Placement Warrants
Jun. 30, 2023
$ / shares
Y
Dec. 31, 2022
Y
$ / shares
Exercise Price    
Fair Value Measurements    
Measurement input, warrants 11.50 11.50
Stock Price    
Fair Value Measurements    
Measurement input, warrants 2.54 2.54
Volatility    
Fair Value Measurements    
Measurement input, warrants 70.0 71.3
Term    
Fair Value Measurements    
Measurement input, warrants | Y 3.44 3.94
Risk-free rate    
Fair Value Measurements    
Measurement input, warrants 4.32 4.03
v3.23.2
Fair Value Measurements - Public Warrants measured at fair value using Level 1 directly observable inputs and Private Placement Warrants (Details) - Recurring - $ / shares
3 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Public Warrants | Level 1    
Reconciliation    
Beginning balance, per share $ 0.46 $ 0.42
Change in fair value (0.15) 0.04
Ending balance, per share 0.31 0.46
Private Placement Warrants | Level 2    
Reconciliation    
Beginning balance, per share 0.86 0.55
Change in fair value (0.43) 0.31
Ending balance, per share $ 0.43 $ 0.86
v3.23.2
Fair Value Measurements - Fair value for the Public Warrants and Private Placement Warrants (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Fair Value, Recurring      
Fair Value Measurements      
Number of warrants outstanding 19,333,303 19,333,303  
Reconciliation      
Balance at the beginning $ 11,779 $ 9,117  
Change in fair value (4,987) (2,325)  
Balance at the end $ 6,792 $ 6,792  
Public Warrants      
Fair Value Measurements      
Number of warrants outstanding 12,684,423 12,684,423 11,666,636
Public Warrants | Fair Value, Recurring | Level 1      
Fair Value Measurements      
Number of warrants outstanding 12,684,423 12,684,423  
Reconciliation      
Balance at the beginning $ 5,576 $ 4,900  
Change in fair value (1,644) (968)  
Balance at the end $ 3,932 $ 3,932  
Private Placement Warrants      
Fair Value Measurements      
Number of warrants outstanding 6,648,880 6,648,880 7,666,667
Private Placement Warrants | Fair Value, Recurring | Level 2      
Fair Value Measurements      
Number of warrants outstanding 6,648,880 6,648,880  
Reconciliation      
Balance at the beginning $ 6,203 $ 4,217  
Change in fair value (3,343) (1,357)  
Balance at the end $ 2,860 $ 2,860  
v3.23.2
Warrant Liabilities (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Warrant Liabilities          
Change in fair value of warrant liabilities $ 4,987 $ 27,473 $ 2,325 $ 28,183  
Warrants          
Warrant Liabilities          
Class of warrant or right, number of securities called by each warrant or right 1   1    
Exercise price of warrants $ 11.50   $ 11.50    
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability value $ 101,253   $ 101,253    
Public Warrants          
Warrant Liabilities          
Number of warrants outstanding 12,684,423   12,684,423   11,666,636
Private Placement Warrants          
Warrant Liabilities          
Number of warrants outstanding 6,648,880   6,648,880   7,666,667
v3.23.2
Stockholders' Equity - Stock options exercised (Details) - Common Stock - shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Stockholders' Equity            
Stock options exercised (in shares) 346,676 1,679,954 656,180 6,212,964 2,026,630 6,869,144
Shares issued under ESPP (in shares) 129,928       129,928  
Shares issued upon vesting of RSUs (in shares) 163,148   20,672   163,148 20,672
v3.23.2
Stockholders' Equity (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Stockholders' Equity        
Cash received from options exercised     $ 184 $ 354
Cash received from shares issued under the ESPP $ 214 $ 0 214 0
Equity Incentive2014 Plan [Member]        
Stockholders' Equity        
Cash received from options exercised $ 34 $ 84 $ 184 $ 354
v3.23.2
Stock Based Compensation - Compensation costs (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Compensation costs        
Equity-based compensation cost $ 2,923 $ 2,314 $ 5,145 $ 3,910
Unrecognized compensation costs related to restricted stock units 34,327 25,316 34,327 25,316
Restricted stock units (RSUs)        
Compensation costs        
Equity-based compensation cost 954 514 1,589 514
Employee stock option        
Compensation costs        
Equity-based compensation cost 1,889 $ 1,800 3,476 $ 3,396
ESPP        
Compensation costs        
Equity-based compensation cost $ 80   $ 80  
v3.23.2
Stock Based Compensation - Stock options and Restricted stock units (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Restricted stock units (RSUs)      
Restricted Stock Units.      
Outstanding at beginning of period 2,766,573 1,057,980 1,057,980
Granted 1,753,207 1,797,034  
Vested (215,553)    
Forfeited (47,181) (88,441)  
Outstanding at end of period 4,257,046 2,766,573 4,257,046
Employee stock option      
Number of Shares      
Outstanding at beginning of period 26,097,071 25,998,172 25,998,172
Granted 1,904,016 3,272,873  
Exercised (346,676) (1,679,954)  
Forfeited or expired (466,635) (1,494,020)  
Outstanding at end of period 27,187,776 26,097,071 27,187,776
v3.23.2
Stock Based Compensation - Fair value of options granted (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Stock Based Compensation    
Approximate risk-free rate 4.17% 2.84%
Volatility 46.91% 44.69%
Average expected life (years) 6 years 6 years
Weighted-average grant date fair value $ 2.80 $ 7.26
Estimated fair value of total stock options granted (in thousands) $ 7,815 $ 5,659
v3.23.2
Earnings (Loss) Per Share - Schedule of reconciliation of basic weighted average common shares outstanding to diluted weighted average shares outstanding (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Earnings (Loss) Per Share        
Net income (loss) attributable to common stockholders $ (12,205) $ 13,667 $ (31,365) $ 3,321
Weighted average shares outstanding - basic 178,063,573 174,128,230 177,502,037 173,266,760
Weighted average shares outstanding - diluted 178,063,573 174,703,533 177,502,037 173,566,001
Earnings (loss) per share - Basic $ (0.07) $ 0.08 $ (0.18) $ 0.02
Earnings (loss) per share - Diluted $ (0.07) $ 0.08 $ (0.18) $ 0.02
v3.23.2
Earnings (Loss) Per Share - Schedule of potentially dilutive securities excluded from the diluted loss per share calculation (Details) - shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Earnings (Loss) Per Share    
Total potentially dilutive securities 47,805,769 48,168,899
Warrants    
Earnings (Loss) Per Share    
Total potentially dilutive securities 19,333,303 19,333,303
2014 & 2021 Equity Incentive Plan - Stock Options    
Earnings (Loss) Per Share    
Total potentially dilutive securities 25,892,666 27,161,312
2021 Equity Incentive Plan - Restricted Stock Units    
Earnings (Loss) Per Share    
Total potentially dilutive securities 2,474,393 1,674,284
2021 Employee Stock Purchase Plan    
Earnings (Loss) Per Share    
Total potentially dilutive securities 46,352  
Contingently Issuable Common Stock    
Earnings (Loss) Per Share    
Total potentially dilutive securities 59,055  
v3.23.2
Leases - Components of lease (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Sep. 01, 2021
Leases        
Operating lease renewal term (in years)     5 years 5 years
Finance lease costs:        
Amortization of right-of-use assets $ 47 $ 91    
Interest on lease liabilities 13 25    
Operating lease costs 290 580    
Total lease expense $ 350 $ 696    
v3.23.2
Leases - Components of supplemental cash flow information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Leases    
Operating outgoing cash flows - finance lease $ 14 $ 26
Financing outgoing cash flows - finance lease 74 141
Operating outgoing cash flows - operating lease 283 567
Right-of-use assets obtained in exchange for new finance lease liabilities: $ 79 $ 89
v3.23.2
Leases - Lease term and discount rate (Details)
Jun. 30, 2023
Leases  
Weighted-average remaining lease term - finance lease (in years) 2 years 11 months 23 days
Weighted-average discount rate - finance lease 6.20%
Weighted-average remaining lease term - operating lease (in years) 9 years 8 months 15 days
Weighted-average discount rate - operating lease 6.90%
v3.23.2
Leases - Schedule of future minimum payments (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Finance Lease  
2023 (remaining six months) $ 174
2024 349
2025 234
2026 109
2027 37
2028 16
Total 919
Less present value discount 77
Total lease liabilities 842
Operating Lease  
2023 (remaining six months) 571
2024 1,173
2025 1,210
2026 1,248
2027 1,288
2028 1,329
Thereafter 5,244
Total 12,063
Less present value discount 3,158
Total lease liabilities $ 8,905
v3.23.2
Related Party Transaction (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Defined Benefit Plan Disclosure [Line Items]        
Revenue from Related Parties $ 4,906 $ 2,582 $ 8,698 $ 4,778
BMW        
Defined Benefit Plan Disclosure [Line Items]        
Amounts due from related party 2,477   2,477  
Revenue from Related Parties $ 3,470   $ 6,470  
v3.23.2
Income Taxes (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Taxes        
Effective tax rate 0.00% 0.27% 0.00% 0.49%

Solid Power (NASDAQ:SLDP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Solid Power.
Solid Power (NASDAQ:SLDP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Solid Power.